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ABSTRACT 
The thesis starts with characterization of alginate that involved the viscosity, ageing, and 
degradation of different concentrations of alginate. Live/Dead, MTT, and Hoechst 33258 
assays were used to investigate cell viability and proliferation in alginate discs. Pulsed-low 
intensity ultrasound (PLIUS) treatment was applied to cells encapsulated in alginate to see if 
it has an effect on viability/proliferation of encapsulated cells (Hoechst 33258 assay), 
extracellular matrix (ECM) deposition (Alcian blue staining, hydroxyproline and 
glycosaminoglycan (GaG) assay) and cell morphology (scanning electron microscopy 
(SEM)). Study of cell behaviour in alginate discs showed that by altering both alginate 
concentration and cell seeding density, cell proliferation in alginate can be controlled. PLIUS 
in conjunction with growth factors (ascorbic acid and TGF-β1) leads to a higher amount of 
collagen production for 3T3 cells when compared to PLIUS alone. However, PLIUS exposure 
alone leads to a greater increase in HDF cell proliferation and collagen production than when 
supplemented with growth factors. No effect was seen on chondrocytes when PLIUS was 
applied. SEM images showed no damage to cells as a result of PLIUS exposure. These results 
indicate that PLIUS treatment of cells encapsulated in alginate showed a potential effect for 
enhancing ECM production by cells in culture. 
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 Glossary 
2D Two dimension 
3D Three dimension 
Ca2+ Calcium ion 
CaCl2 Calcium chloride 
CO2 Carbon dioxide 
cP Centipoise (1 cP = 0.001 Pa.s) 
DMB 1,9 dimetylmetylene blue dye 
DMEM Dulbecco’s modified Eagle’s medium 
ECM Extracellular matrix 
g/l gram/litre 
GaG Glycosaminoglycan 
HCl Hydrochloric acid 
HDF Human dermal fibroblast 
HEPES 2-[4-(2-hydroxyethyl)piperazin-1-yl] ethanesulfonic acid 
MgCl2 Magnesium chloride 
mM Milimolar 
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MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
Mw Molecular mass ( mass ratio of one molecule of a substances to 1/12 of 
the atom carbon-12) 
Na+ Sodium ion 
Pa.s SI unit of viscosity 
PBS Phosphate-buffered saline 
P-DMBA p-dimethylaminobenzaldehyde 
PEG Polyethylene glycol 
PLIUS Pulsed-low intensity ultrasound 
RGD Sequence of the three amino acids: arginine, glycine, aspartic acid 
SEM Scanning electron microscopy 
TGF-β Transforming growth factor 
v/v% Percentage volume of solute divided by volume of solvent 
wt/vol Mass of solute divided by the volume of solvent. 
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1. INTRODUCTION 
In this study, focus will be on therapeutic ultrasound or specifically pulsed-low intensity 
ultrasound (PLIUS) as a potential physical method for stimulation of enhanced extracellular 
matrix (ECM) production by encapsulated cells in culture. In tissue engineering, many studies 
have used biochemical stimulation (growth factors) for promoting ECM production by cells in 
culture [Bittencourt et al., 2009, Chojkier et al., 1989, Clark et al., 1995, Kim et al., 2009, 
Neidert et al., 2002, Park et al., 2009, Ross and Tranquillo 2003]. However, physical 
stimulation offers several advantages such as providing a non-invasive treatment and lack of 
toxicity to living cells [Doan et al., 1999, Iwashina et al., 2006]; also it can be used alone or 
in conjunction with biochemical stimulation [Miyamoto et al., 2005].  
 
This thesis will investigate the suitability of alginate as a medium for cell 
viability/proliferation, and of PLIUS as a method for physical stimulation of ECM production 
by the encapsulated cells. Chapter 2 will introduce alginate as a scaffold, therapeutic 
ultrasound, and at the same time provide some other basic background information that is 
necessary for understanding this thesis. Further detailed information will be given at the 
beginning of each chapter. The experimental work will be divided into five chapters, as 
described below. 
 
Investigating alginate properties: this chapter will focus on the rheology of alginate 
solutions subsequently used for cell encapsulation. It will cover the viscosity, ageing and 
degradation of different concentrations of alginate. This study aimed to determine whether the 
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concentration, ageing and the degradation of alginate could have an influence on the 
encapsulated cells.  
 
Viability and proliferation of 3T3 cells: this chapter presents a detailed study of the 
influence of different alginate concentrations with different seeding densities on cell 
viability/proliferation, and time of spheroid formation occuring in culture. These variables are 
important for understanding cell behaviour in alginate discs. 3T3 cells are mouse fibroblasts 
and fibroblasts are responsible for making ECM. In this preliminary study, 3T3 cells were 
used to see if alginate is a good material for cell encapsulation. This is important before 
further study can be carried out to investigate ECM production by cells in culture.  
 
PLIUS effect on 3T3 cells: PLIUS use intensities low enough to avoid promoting thermal 
effects on the cells. This is essential as high temperatures could kill the treated cells. Many 
previous studies reported that PLIUS showed a positive effect on cell proliferation [Doan et 
al., 1999, Iwashina et al., 2006] and increasing ECM production of treated cells [Iwashina et 
al., 2006, Miyamoto et al., 2005, Schumann et al., 2006, Zhang et al., 2003] . However, these 
previous studies used different frequencies, intensities and duty cycles for PLIUS than in the 
present study. Furthermore, there are no previous studies on PLIUS treatment of 3T3 cells 
cultured in alginate. For this reason, this study was carried on to investigate effect of PLIUS 
on 3T3 mouse fibroblasts 
 
PLIUS effect on human dermal fibroblast (HDF) cells: this chapter investigates the effect 
of PLIUS on human dermal fibroblasts (HDF), as a continuation of the study of 3T3 mouse 
fibroblasts. This is essential to see if there is any difference to the observations/findings when 
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using different fibroblasts from a different species. If this study with HDF cells shows a 
promising effect, it would demonstrate potential for the application of tissue engineering to 
treat some human health problems, such as sun-damaged-skin and diabetes mellitus.  
 
PLIUS effect on chondrocytes: the chondrocytes were originally from calf knee cartilage 
and are reported to require a 3D culture system in order to maintain their morphology and 
increased their ECM production [Bittencourt et al., 2009]. The study of chondrocytes follows 
naturally from the work on fibroblasts where alginate was used as a 3D scaffold material. 
Furthermore, the effect of PLIUS on chondrocytes in 3D culture was investigated. The results 
could be beneficial for articular cartilage repair after damage by disease or trauma.  
 
In the final chapter of the thesis, the overall conclusions will be described. These concern the 
effect of different alginate concentrations, different seeding densities, and PLIUS treatment 
(with or without growth factors) on several cells types, that produce ECM, in 3D culture in 
alginate gels. 
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2. BACKGROUND TO THE STUDY 
2.1 Tissue engineering 
The purpose of tissue engineering is to use living cells to produce replacements for tissue lost 
as a result of trauma or disease [Malafaya et al., 2007, Marler et al., 1998, Neidert et al., 
2002, Saltzman 2004]. Surgical techniques for dealing with tissue loss such as organ 
transplantation, autografts (tissue transfer from a healthy site to an affected site in the same 
individual) and replacement of tissue with mechanical devices have been developed [Marler 
et al., 1998]. While these methods are very useful, they have limitations. For example, organ 
transplantation may be restricted by a shortage of donors, tissues transferred within an 
individual may be defective and transferring tissues to a different individual could lead to 
rejection [Eisenbarth 2007, Langer and Vacanti 1993, Marler et al., 1998].  
 
Mechanical devices also have problems: they may wear out in use and are not repaired by 
biological mechanisms [Marler et al., 1998], they may induce inflammation and/or infection 
and may necessitate further treatment e.g. administration of anti-coagulants following heart-
valve replacement [Marler et al., 1998]. Additionally, these mechanical devices do not grow 
as the body of the recipient grows [Marler et al., 1998]; this is an important consideration 
when repairing some tissues in children. Three principle strategies have been explored for 
creating new tissues: the injection of isolated cells or cultured cells to the damaged area, 
implantation of tissue that has been assembled in vitro from cells cultured in scaffolds and in 
situ tissue regeneration [Griffith and Naughton 2002, Marler et al., 1998]. For cellular 
implantation, individual cells/small aggregates of cells from the patient or donor are injected 
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to the lesion area. For tissue implantation, a 3D culture system (cells and scaffold) is 
developed in vitro and implanted to the patient once the tissue reaches maturity. For in situ 
implantation, a scaffold is implanted directly in the damaged tissue and the body will 
stimulate its own cells to promote the repair [Griffith and Naughton 2002].  
2.2 We want our cells to make ECM 
2.2.1 ECM 
ECM is an extracellular product secreted by cells that gives support and strength to the cells 
to perform their important roles in living systems [Badylak et al., 2008, Hukins et al., 1995]. 
ECM consist a mixture of components such as collagens, glycoproteins and 
glycosaminoglycan (GaG) [Badylak et al., 2008, Harbers and Grainger 2006, Hukins et al., 
1995].  
 
Since that the composition of ECM depends on the cells’ location in the body, different 
tissues (like tendon, and cartilage) have different physical properties because they have 
different proportions of macromolecular components [Hukins et al., 1995]. Additionally, cell-
matrix interactions are important for the function of the tissue in living systems [Harbers and 
Grainger 2006, Hukins et al., 1995]. For example, fibroblasts in tendon produce a high 
proportion of fibrillar collagens to provide tensile strength to the tissue. In contrast, cartilage 
has a high GaG concentration to bind water and so resist compression of the tissue [Hukins et 
al., 1995].  
2.2.2 Proteoglycan matrix components  
GaGs are polymers that are composed of repeating sugar units. GaGs (except for hyaluronic 
acid) are covalently bound to proteins in ECM, the resulting molecules are called 
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proteoglycans [Hukins et al., 1995, Ratner and Bryant 2004]. GaGs can be divided into four 
major group depending on their chemical composition: keratan sulfates, heparin sulfates and 
heparin, chondroitin sulfates and dermatan sulfates and hyaluronic acid [Hukins et al., 1995, 
Ratner and Bryant 2004]. GaGs are negatively charged and so bind to water [Harbers and 
Grainger 2006, Saltzman 2004] with the result that cartilage, for example, consists of about 
80% water [Hukins et al., 1995]. When tissues are dehydrated their properties change 
dramatically; therefore, the water content of the tissue is important for maintaining its 
physical properties and functions [Hukins et al., 1995].  
 
As mentioned before, different tissue locations will have different compositions of ECM. 
Therefore, different types of GaG exist in the ECM of different tissues [Hukins et al., 1995]. 
For example, chondroitin sulfates occur in skin for scarless wound repair in fetal [Adzick and 
Lorenz 1994, Hukins et al., 1995]and cartilage and dermatan sulfates occurs in skin and 
tendon [Hukins et al., 1995].  
2.2.3 Non-proteoglycan matrix components 
Components other than proteoglycans and hyaluronic acid include collagen and fibronectin. 
These non-proteoglycan matrix components have been widely used to encourage cell grow 
and differentiation in vitro and in vivo [Badylak 2007]. 
 
The most abundant protein in the body, and the main component (other than water) in the 
ECM of many tissues (e.g. tendon skin and ligaments) is collagen; it is secreted by fibroblasts, 
chondrocytes, tenocytes and endothelial cells [Doroski et al., 2007, Saltzman 2004]. Collagen 
consists of a polypeptide chain with a repeating amino-acid sequence glycine-X-Y, where X 
is often proline and Y is often hydroxyproline [Badylak et al., 2008, Hukins et al., 1995]. The 
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most common types are I, II and III that form fibrils (i.e fibrillar collagen) that can be 
observed by electron microscopy [Doroski et al., 2007, Hukins et al., 1995]. An important 
characteristic of collagen is the ability to provide strength by resisting forces that tend to pull 
the tissue apart [Doroski et al., 2007, Hukins and Aspden 1985, Hukins et al., 1995]. In tissue 
engineering, collagen has been used as a scaffold since that it is from a natural source. Cells 
can grow/proliferate properly, because of their interactions with the collagen scaffold [Ungaro 
et al., 2005]. There are many different types of collagen in the body that have different 
chemical compositions; the main types of collagen that form fibres to reinforce ECM are type 
I (in tendon) and type II (in many forms of cartilage, such as in finger, elbow and ankle joints) 
[Hukins et al., 1995]. 
 
Hyaluronic acid is also known as hyaluronan or hyaluronate. It is an important GaG 
component of many connective tissues, especially soft or fluid tissues like synovial fluid 
[Drury and Mooney 2003, Mano et al., 2007]. However because it is not bound to protein to 
form a proteoglycan, it differs from the other GaGs; also, unlike the others, it does not have 
sulfate groups [Saltzman 2004]. Hyaluronic acid is important for wound healing, embryonic 
development, transporting metabolites and nutrients, cell migration and cell proliferation [Lee 
and Mooney 2001, Saltzman 2004, Ungaro et al., 2005]. In tissue engineering applications, it 
has shown to have excellent potential for artificial skin, wound healing and soft tissue 
augmentation [Lee and Mooney 2001]. However, it requires thorough purification to remove 
all of the impurities including toxins that could transmit diseases and cause immune response 
problems. 
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Fibronectin is a glycoprotein that mediates cell-ECM interactions [Hukins et al., 1995, 
Minuth et al., 2005]. The binding of fibronectin to collagen and heparin contributes to the 
organization of ECM and also affects cell morphology, migration and differentiation [Mano et 
al., 2007, Saltzman 2004, Ungaro et al., 2005]. Previous reports also mentioned that 
fibronectin plays an important role in cell adhesion by interacting with cells to promote cell 
attachment to ECM [Ruoslahti 1988]. This ability comes from a sequence of three amino 
acids, arginine-glycine-aspartic acid (abbreviated to RGD) that interacts with the cell surface 
[Badylak et al., 2008, Hukins et al., 1995].  
2.3 Ideal scaffold material  
Generally, materials that are implanted into the body cause an immune response because they 
do not exist there naturally [Jones 2005]. Many of them are toxic; however, there are also 
biocompatible materials that are suitable to be implanted in the body [Jones 2005]. 
 
Ideally, a scaffold should acts as a template for the cells to grow on and then, later, regenerate 
new tissue that can function well when implanted to the lesion area of the patient [Jones 
2005]. The scaffold material should be non-toxic, biocompatible, and easy to sterilize; in 
addition, it should allow cellular interactions, and resemble mechanically the surrounding 
tissue [Eisenbarth 2007, Kim et al., 2000, Mano et al., 2007]. 
2.4 Natural polymer as a scaffolds 
2.4.1 Alginate 
Calcium alginate forms a hydrogel that has been widely used in tissue engineering due to its 
structural similarity to the GaGs in ECM, low toxicity, cost and spontaneous or mild gelation 
conditions that have no deleterious effect on the growth of a range of cell types [Khattak et 
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al., 2006, Wan et al., 2008]. Alginate is abundant in nature and can be found in marine brown 
algae and some soil bacteria [Simpson et al., 2004]. Sodium alginate solution turns into a 
hydrogel when binds with divalent cations such as Ca2+, resulting in a three dimensional 
network described by the “egg-box model” (Figure 2.1) [Braccini and Perez 2001, Grant et 
al., 1973, Simpson et al., 2004]. Furthermore, the physical properties of alginate also vary 
widely depending on its molecular weight [Draget et al., 1994] and proportion of guluronic 
and mannuronic acid residues; these are the two sugar residues that are repeated in the 
polysaccharide chain and guluronic acid is responsible for Ca2+ ions binding in the egg-box 
model [Simpson et al., 2004]. For example, by changing the Ca2+ ions concentration the 
strength of the gel network of alginates with a high guluronic acid content can be altered but 
alginates with high in mannuronic acid content are less sensitive to such changes [Simpson et 
al., 2004, Wan et al., 2008]. By doing this, the growth of encapsulated cells can be controlled 
[Simpson et al., 2004].  
 
However, the disadvantages of ionically crosslinked alginate hydrogels is that they undergo 
slow, uncontrolled dissolution [Drury and Mooney 2003, Lee and Mooney 2001]. When 
placed in media, monovalent ions such as Na+ ions can also compete with Ca2+ ions and so 
disrupt the gel over time [LeRoux et al., 1999, Segeren et al., 1975, Wan et al., 2008]. To 
overcome this limitation, barium and copper-crosslinked alginate gels are more stable in 
aqueous environment but these cations are toxic to cells [Kuo and Ma 2008].  
 
Another potential limitation in using alginate gels in tissue engineering is the lack of cellular 
interaction since alginate is known to discourage protein adsorption and is unable to 
specifically interact with mammalian cells [Lee and Mooney 2001, Rowley et al., 1999, Shih-
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Feng et al., 2010, Smetana 1993]. Furthermore, previous studies also reported that viability or 
proliferation of the cells is limited due to lack of adhesion molecules available within the 
alginate matrix for the cells to adhere to [Shih-Feng et al., 2010]. Those cells that seek 
attachment will attach to one another to form cell spheroids/agglomerates as proliferation 
occurs [Bartold and Page 1985, Glicklis et al., 2004]. To overcome this, there are varieties of 
short amino acid sequences found in the ECM molecules that can mediate cell adhesion. As 
mentioned in section 2.2.3, the fibronectin-derived adhesion peptide (RGD) is commonly 
coupled with the alginate and it has been shown that muscle cells adhere and proliferate when 
in contact with RGD-modified alginate [Augst et al., 2006].  
 
This study shows that RGD-modified alginate contributes to cell proliferation and attachment 
but RGD itself is very expensive and so does not provide a practical route for large scale 
production in tissue engineering. Alternatively, growth factor tethering and incorporation are 
other avenues by which hydrogels can be modified to regulate the functions of interacting 
cells [Mann et al., 2001]. However, there is no literature cited in this thesis, discussing that 
lack of cell adhesion could also have a bad impact on the ECM production. Consequently, it is 
worth trying unmodified alginate to encapsulate cells and induce them to produce ECM in 
culture. 
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igure 2.1: A schematic figure of the “egg-box” model. Gelation of alginate solution with the 
ddition of Ca2+ ions, based on a figure in Wan et al. (2008). 
.4.2 Other natural polymers 
hitosan can be prepared by chemical treatment of the polysaccharide chitin [Lee and 
ooney 2001] that can be widely found in many insect exoskeletons, mollusc shells, fungi 
nd crustacean shells [Riddle and Mooney 2004]. It has been used in many biomedical 
pplications especially in tissue engineering because it has biocompatibility, low toxicity, 
ructural similarity to GaGs, and the ability to be degraded by enzymes such as chitosanase 
nd lysozyme [Lee and Mooney 2001, Singh and Ray 2000]. However, it has been reported 
at chitosan supports almost no fibroblast proliferation [Mori et al., 1997, Ueno et al., 2001] 
r ECM production by fibroblasts in vitro [Ueno et al., 2001].  
 has been explained in the previous section (2.2.3) that collagen is an important component 
f ECM [Burdick and Stevens 2005, Mano et al., 2007]. Since it is naturally derived, many 
udies have used it as a scaffold material in tissue engineering, usually denatured when it 
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forms a hydrogel [Burdick and Stevens 2005]. However, collagen is mechanically weak and 
can quickly degrade in vitro [Ding et al., 2008, Lee and Mooney 2001]. 
Since there are some drawback in using collagen hydrogels, fibrin hydrogels can be used as 
an alternative [Grassl and Tranquillo 2006]. Fibrin is important in wound healing and 
homeostasis (the processes whereby the body/cell maintains the equilibrium of its internal 
environment when there is a change in the external environment) and has also been used as a 
sealant in surgery [Lee and Mooney 2001, Malafaya et al., 2007, Mano et al., 2007]. It can be 
sourced from the patient’s own blood and so reduce immune rejection problems [Lee and 
Mooney 2001, Mano et al., 2007]. However, fibrin also has its limitation in tissue engineering 
applications. They are limited mechanical strength, shrinkage of the gel during flat sheet 
formation and rapid degradation before proper tissue formation occurs [Ahmed et al., 2008, 
Jockenhoevel et al., 2001, Lee and Mooney 2001, Mol et al., 2005]. 
 
2.5 Why use alginate as a scaffold material? 
Hydrogels, both synthetic and natural, are promising tissue engineering scaffolds for three 
reasons: their water content resembles that of ECM; they can be formed in situ to make 
implantation easier; and they can encapsulate cells during gel formation [Rowley et al., 1999, 
Wang et al., 2003a]. Any hydrogel scaffold must initially be sufficiently strong to survive in 
the in vivo environment and protect encapsulated cells and new tissue while eventually 
degrading to enable new tissue to form [Wang et al., 2003a]. The new tissue can then 
integrate into the surrounding tissues while the hydrogel scaffold degrades, eliminating any 
need for further surgery [Abbah et al., 2008].  
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When compared to other type of hydrogel, alginate has several advantages in tissue 
engineering applications. Because of the mild gelation conditions, alginate has been shown to 
support the growth of a range of different cell types in tissue engineering applications, 
including: pancreatic islet cells [Lim and Sun 1980, Peirone et al., 1998], fibroblasts, and 
chondrocytes [Hunt et al., 2009, Lee et al., 2003, Pokrywczynska et al., 2008]. More recent 
work has involved the encapsulation and differentiation of mesenchymal stem cells to 
cartilage-forming chondrocytes [Gold 1981, Lee et al., 2007, Ma et al., 2003].  
 
In contrast, previous findings reported that encapsulation in chitosan almost suppresses 
fibroblast proliferation [Mori et al., 1997, Ueno et al., 2001]. Encapsulation in alginate 
preserves chondrocyte phenotype and increases proteoglycan accumulation gradually; this 
does not happen in collagen gels [vanSusante et al., 1995]. Furthermore, a previous study 
reported that fibroblasts  encapsulated in alginate can be maintained in culture for up to 33 
days [Hunt et al., 2009]; this is an advantage of using alginate as compared to fibrin that 
degrades rapidly in culture [Ahmed et al., 2008, Jockenhoevel et al., 2001, Mol et al., 2005].  
 
Using alginate as a scaffold material to culture chondrocytes has several advantages over 
culture in monolayer. A previous study on culturing chondrocytes in alginate beads, reported 
that the cells are normally associated with ECM, and as a consequence, may require a scaffold 
[Masuda et al., 2003]. The expansion of chondrocytes in alginate beads was also shown to 
provide a potential culture system for cartilage repair using cells cultured from the person’s 
own tissue [Lee et al., 2003]. This is one of the promising effects of alginate when using 
chondrocytes in this study. 
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2.6 The cells  
Cells that are used in tissue engineering can be obtained from a variety of donors such as from 
primary tissues or cell lines [Palsson and Bhatia 2003]. Primary tissues can be from the same 
individual (autologous), from the same species but a different individual (allogenic), from a 
genetically identical donor such as a homozygous (identical) twin (syngeneic) and from 
different species (xenogenic). Cell lines are cells that can proliferate indefinitely after they 
have been genetically modified [Marler et al., 1998, Palsson and Bhatia 2003]. 
 
Figure 2.2, shows how specific cells types can be maintained and proliferated in a 2D culture 
system. The specific cell types can be incorporated into a suitable scaffolds where these 
scaffolds must be compatible with the cells in in vitro or/and in vivo [Vacanti and Vacanti 
2000]. As the cells grow in the scaffold, they produce their own ECM. Then, a tissue-like 
structure is formed and when this material reaches maturity it can be transplanted to the 
patient [Khademhosseini and Langer 2007]. 
 
 
Figure 2.2: The tissue engineering approach to developing organ or tissue replacement using 
cultured cells. Based on an idea from Lee and Mooney (2001). 
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2.6.1 Fibroblasts  
The most common cell types in connective tissue ECM are fibroblasts. They synthesize 
collagen and other components of ECM (e.g. glycoproteins and GaGs) to maintain and 
support a structural framework in connective tissue such in tendons and ligaments [Doroski et 
al., 2007, Salem et al., 2002]. 
 
As mentioned in section 2.2.3 and 2.4.2, collagen is an ECM component that has been used 
widely in tissue engineering applications. Fibroblasts (Figure 2.3) are one of the cells that 
synthesize collagen and can easily be cultured in simple media as long as serum is present 
[Freshney 2005]. Collagen type I is most common type made by fibroblasts [Freshney 2005]. 
Furthermore, in the literature, only one previous study [Pokrywczynska et al., 2008] has 
attempted to encapsulate fibroblasts in alginate. Hence, observing the cell behaviour in the 
alginate, is a good starting point, as a preliminary study. This will be discussed in detail in 
Chapter 3 and Chapter 4. 
  
     
Figure 2.3: Fibroblasts. (a): 3T3 mouse fi
description) (b): Human dermal fibroblasts (seeb a 15 
 
broblasts (see section 4.3.1 for a detailed 
 section 6.3.2 for a detailed description).  
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2.6.2 Calf chondrocytes 
Chondrocytes (Figure 2.4) are a specialized type of fibroblast and act as one of the cellular 
components of articular cartilage [Hukins et al., 1995, Noriega et al., 2007]. These cells 
synthesize collagen type II and GaG for mechanical support, and growth of articular cartilage 
[Archer and Francis-West 2003, Archer et al., 1990, Choi et al., 2006].  
 
Several studies have addressed the effect of PLIUS on cartilage at the cellular level 
(chondrocytes) by showing positive effects on cell proliferation and the production of ECM 
[Hsu et al., 2006, Parvizi et al., 1999, Zhang et al., 2003]. Because of this, many efforts have 
been made to develop efficient methods for expanding the isolated chondrocytes in vitro 
without hampering their phenotypic characteristics [Choi et al., 2006, Hunziker 2002].  
 
In addition, chondrocytes need to be cultured in 3D (scaffold) form to maintain their rounded 
and cartilage-forming phenotypes as this is critical for the regeneration of cartilage in vitro 
[Lee et al., 2003]. Furthermore, chondrocytes that are cultured in 2D (monolayer) have a 
tendency to dedifferentiate to fibroblasts [Bittencourt et al., 2009, Choi et al., 2006, Lee et al., 
2003].  
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Figure 2.4: Calf chondrocytes (see section 7.3.1 for a detailed description). 
2.7 Growth factors 
 2.7.1 Ascorbic acid 
A previous report stated that ascorbic acid is a growth factor that is involved in collagen gene 
expression by fibroblasts [Chojkier et al., 1989]. It functions as a cofactor for specific 
enzymes (lysyl hydroxylase and prolyl hydroxylase) that are essential for collagen synthesis. 
It is involved in the hydroxylation process where proline forms hydroxyproline and lysine 
forms hydroxylysine [Pinnell 1985, Tajima and Pinnell 1982]. Hydroxyproline is one of the 
amino acids in the collagen sequence and is needed for collagen helix formation [Badylak et 
al., 2008, Hukins et al., 1995, Pinnell 1985]. Furthermore, collagen cross-linking would be 
weak without hydroxylysine [Pinnell 1985]. Previous studies also mentioned that ascorbic 
acid has an effect on the translation and transcription of genetic information into the collagen 
amino acid sequence [Pinnell 1985, Tajima and Pinnell 1982].  
 
Previous studies also reported that ascorbic acid increases ECM synthesis in chondrocytes, 
human fibroblasts and human aortic smooth muscle cells [Bittencourt et al., 2009, Chojkier et 
al., 1989, Kim et al., 2009].  
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2.7.2 Transforming growth factor beta 1 (TGF-β1) 
TGF-β1 was reported to be involved in stimulating collagen and GaG biosynthesis by 
chondrocytes, and fibroblasts in cultured rabbit marrow mesenchymal stem cells and neonatal 
rat smooth muscle cells [Clark et al., 1995, McAnulty 2007, Neidert et al., 2002, Park et al., 
2009, Redini et al., 1988, Ross and Tranquillo 2003].  
 
However, it is most common in regulation of ECM production by fibroblasts and in wound 
healing [McAnulty 2007]. In wound healing, it is involved in differentiation of fibroblasts 
into specialised cells called myofibroblasts [Hashimoto et al., 2001, McAnulty 2007, Petrov 
et al., 2002]. If fibroblast function is impaired or inappropriate, diseases resulting from 
diminished or excess ECM deposition can occur [Hashimoto et al., 2001, McAnulty 2007, 
Phan 2008].  
2.8 Therapeutic Ultrasound 
2.8.1 Ultrasound 
Ultrasound is sound with a frequency (greater than about 20 kHz) which is too high for 
human hearing [Doan et al., 1999]. Therapeutic ultrasound is used in medicine for tissue 
repair [Dalecki 2004]. It usually has a frequency between 1 and 3 MHz with an intensity 
range of 0.1 to 2.0 W/cm2  [Doan et al., 1999]. It is a wave that transports mechanical energy; 
although it causes heat; this is simply a consequence of supplying mechanical energy at this 
frequency, rather than being anything additional or special [Doan et al., 1999, Ozgonenel et 
al., 2009]. 
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2.8.2 Pulsed-low intensity ultrasound (PLIUS) 
(PLIUS) or pulsed low intensity (less than 1 W/cm2) ultrasound whose intensity is low 
enough to have minimal thermal or destructive properties [Min et al., 2007, Takayama et al., 
2007]. This was confirmed from the PLIUS characterization in my work that showed that the 
temperature rise was ≤ 0.3°C within a 5 min exposure (Appendix A2). PLIUS is known to 
accelerate bone regeneration, increase cell proliferation, protein synthesis and cytokine 
production by fibroblasts, osteoblasts and monocytes in culture [Doan et al., 1999, Ikeda et 
al., 2006, Takayama et al., 2007]. PLIUS stimulation also has been shown to effect 
proliferation and matrix deposition of human chondrocytes [Hsu et al., 2006] and increase 
proteoglycan synthesis in a human nucleus pulposus (the central region of the intervertebral 
disc) cell line [Kobayashi et al., 2009]. There were also reports showing that PLIUS does not 
affect cell viability and can increase proteglycan synthesis by cells encapsulated in alginate 
[Iwashina et al., 2006, Miyamoto et al., 2005, Zhang et al., 2003]. However, studies on 
PLIUS with frequency and intensity used in the present study on alginate encapsulated 3T3 
fibroblast, HDF and calf chondrocytes have not been reported before. Although ultrasound 
has widespread use in medicine, there is little scientific evidence about what it does [Tsai et 
al., 2006]. The present study provides a good opportunity to investigate how PLIUS effect on 
different cells types from different sources.  
2.9 Assay of cell behaviour in culture 
2.9.1 Hydroxyproline assay 
Hydroxyproline is formed from the hydroxylation of proline by the enzyme prolyl 
hydroxylase during collagen synthesis [Pinnell 1985, Tajima and Pinnell 1982]. As mentioned 
in section 2.2.3, hydroxyproline is a major component of and is always present in collagen 
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[Badylak et al., 2008, Hukins et al., 1995]. Consequently, measuring hydroxyproline content 
can directly related to collagen content [Reddy and Enwemeka 1996]. Hydroxyproline can be 
assayed by oxidation to a compound related to pyrrole, which may then form a coloured 
compound with p-dimethylaminobenzaldehyde (P-DMBA) [Kyaw and Hlape 1973].  
2.9.2 Glycosaminoglycan (GaG) assay 
1,9 dimethylmethylene blue dye (DMB) is used for GaG detection. This assay relies on the 
changes to the DMB when this cationic dye bind to the anionic sulfate and carboxyl groups in 
the GaG [Enobakhare et al., 1996]. Many previous studies used DMB dye at pH 3.0 and this 
resulted in complications when using alginate as a scaffold material. This is because, alginate 
also has a carboxyl group and at pH 3.0, DMB dye binds to both carboxyl groups (alginate 
and GaG) as well as to sulfate groups in the GaG [Enobakhare et al., 1996]. However, by 
using a pH of 1.5, the dye reaction with alginate can be minimized [Chang et al., 2001]. The 
absorbance of the test samples was measured with light of wavelength 600 nm in the dark to 
maintain the condition of the dye [Farndale et al., 1986]. 
2.10 Rheology 
“Rheology is the study of deformation and flow” [Cogswell 1981]. It means that a liquid will 
change in shape and/or volume (i.e. it will deform) when the liquid molecules move past or 
towards to each other (i.e. when they flow) [Barnes 2000, Harris 1977]. Flow of liquid layers 
past each other is called shear [Barnes 2000].  Flow is initiated by shear stress, as shown in 
Figure 2.3 [Brydson 1981].  
 
The flow of a liquid is restricted by its viscosity [Barnes 2000]. In the case of alginate 
solutions, the thicker the solution (i.e. the higher the alginate concentration), the more difficult 
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for the solution to flow/move and deform [Cogswell 1981]. So when stress is applied to the 
alginate, the material will continues to deform and when the solution become thicker the 
stress that is applied to it needs to be increased to deform and move the alginate solution 
[Cogswell 1981]. A rheometer measures the stress required to induce flow at a controlled 
shear rate [Cogswell 1981]. 
 
There are several factors that affect the viscosity of polymer solutions. These include 
temperature, pressure and molecular weight of the dissolved polymer [Brydson 1981]. The 
effect of temperature on alginate viscosity is demonstrated in chapter 3 (section 3.5.1) and 
Appendix (A1). Molecular entanglement of the polymers also plays an important role [Barnes 
et al., 1989, Cogswell 1981]. In polymer solutions at high concentration, molecular 
entanglement is expected to be higher than in a solution at lower concentration because there 
is less water present. Molecular entanglement also increases when the molecular weight of the 
polymer increases. Thus high molecular weight polymers and high concentrations lead to 
increase the shear stress that applied to the polymer solutions. 
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Figure 2.3: The shear stress which initiates the flow is the force divided by the shaded area. 
Based on an idea by Brydson (1981).  
 
2.11 Research questions 
§ What is the rheology behaviour of alginate solutions with different concentrations? 
§ Is the viability and proliferation of alginate encapsulated cells influenced by different 
concentrations of alginate solutions? 
§ Does PLIUS alone, or PLIUS in conjunction with growth factors, enhance cell 
proliferation and ECM production on 3T3 cells, HDF cells and chondrocytes 
encapsulated in alginate gels? 
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3. INVESTIGATING ALGINATE PROPERTIES 
FOR CELL ENCAPSULATION 
3.1 Introduction 
As discussed in section 2.4.1, alginate solution turns into a hydrogel when the guluronic acid 
residues bind to divalent cations. Its physical properties also can change markedly depending 
on the molecular weight and proportion of guluronic acid. Since calcium alginate has been 
widely used in cell delivery and tissue engineering applications, it is important to reduce the 
possibility that it degrades before the cells can perform their required functions.  
 
In this chapter, the viscosity of alginate solutions to be used for cell encapsulation were 
measured. A decrease in viscosity was used as a measure of alginate degradation (see section 
2.10). The mechanical degradation of the different concentrations of alginate gel were 
determined when maintained in supplemented cell culture medium for up to 28 days. This 
study was carried out to determine whether the alginate concentrations are likely to have an 
influence on the encapsulated cells (discussed later on the Chapter 4 section 4.6). To identify 
the mechanical integrity, viscosity measurements, ageing of alginate solutions (section 3.3.2 
and 3.3.3) and a degradation study (section 3.3.5) were undertaken.  
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3.2 Materials  
Sodium alginate from kelp (brown seaweed) (viscosity = 20-40 cP = 0.02-0.04 Pa.s for a 2% 
solution at 25ºC Cat no: 180947, Batch no: MKBB8173, Mw 120 000-190 000, 
mannuronic/guluronic ratio 1.56), phosphate-buffered saline [(PBS) ( 0.01M phosphate 
buffer, 0.0027 M potassium chloride and 0.137 M sodium chloride, pH 7.4)] and Dulbecco’s 
modified Eagle’s Medium (DMEM), were obtained from Sigma-Aldrich (Poole, Dorset, UK).  
3.3 Methods 
3.3.1 Preparing alginate solution 
Sodium alginate solutions (0.5, 1, 2, and 5 wt/vol% made with double distilled water) for the 
degradation study were autoclaved at 121°C for 15 min to sterilise before being used [Hunt et 
al., 2010]. For the viscosity and ageing studies, sodium alginate solutions (0.5, 1, 2 and 5 
wt/vol%) were prepared with double distilled water without sterilisation. All of the alginate 
solutions were kept at room temperature for the whole experiment.  
3.3.2 Viscosity measurements 
The viscosity of alginate solution (0.5, 1, 2 and 5 % ) was measured using a rotating 
rheometer (AR 1000, Jencons Scientific LTD, Lutterworth, Leicestershire, UK) fitted with a 
40 mm 2° steel cone-plate geometry [Furth et al., 2008, Rezende et al., 2009, Roopa and 
Bhattacharya 2009] with a shear rate up to 1000 (1/s). The rotational speed depended on the 
sample viscosity, computed from means of stress and shear rate (TA Instruments Ltd, 
Crawley, west Sussex, UK). Experiments were run on all of the alginate samples at two 
different temperatures (25°C in Appendix A1 and 37°C). This was done in order to compare 
whether temperature changes have a dramatic effect on the alginate solution. 
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3.3.3 Ageing of alginate solutions 
The ageing (viscosity) of alginate solution (0.5, 1, 2 and 5%) was measured (section 3.3.2) for 
up to 28 days. All of the solutions were kept at room temperature (see section 3.3.2 for a 
detailed description).  
3.3.4 Preparing alginate discs 
Alginate discs were prepared by following Hunt et al’s [Hunt et al., 2010] method, but some 
slight modifications were made for this study. 1 ml of sodium alginate solutions (0.5, 1, 2, and 
5 %) were pipette into a well in a twelve-well plate containing a filter paper that was soaked 
in sterile CaCl2 solution (100 mM), that was placed at the bottom of the well. The alginate 
solution was covered with another filter paper that was also soaked in sterile CaCl2 solution. 
The well was then filled with sterile CaCl2 solution to gel the alginate [Khattak et al., 2006]. 
The resulting suspensions were incubated for 2 h at 37°C with 5% CO2. The resulting discs, 
with an average diameter of 17.25 mm (Figure 3.1) were transferred to a six-well plate, and 
then washed three times with PBS. DMEM (5 ml) was added to each well and the constructs 
incubated at 37°C with 5% CO2; the medium was changed every 3 days for a period of up to 
28 days. When compared to other forms of alginate, the disc is the most appropriate shape to 
achieve cell encapsulation and obtain the number of cell densities per each disc, accurately. 
 
 
Figure 3.1: Alginate disc.  
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3.3.5 Hydrogel degradation study  
The hydrogels were degraded for a period of up to 28 days at 37°C with supplemented 
DMEM. In order to observe the degradation process of the discs at different alginate 
concentrations, they (3 samples each) were removed from the media at each specified day and 
freeze dried for 2 days. The dry mass (Ds) of the alginate disc was measured and the fractional 
loss was determined by dividing Ds by the mass of the sample on day 0 (D0). 
3.4 Statistical analyses 
The Shapiro-Wilk test [Pallant 2007] showed that all of the results were normally distributed 
except on days 2 and day 3 for the alginate disc degradation study. As a consequence, results 
were compared using a one-way ANOVA and Kruskal Wallis tests [Pallant 2007]. 
Differences were considered to be significant if the probability p < 0.05. 
3.5 Results  
3.5.1 Viscosity of different concentration alginate solutions 
Figure 3.2a and 3.2b shows that the viscosity decreases with increasing shear rate which 
indicated shear-thinning behaviour [Rezende et al., 2009]. This is clearly observed with a 
high concentration of alginate solution but the shear thinning behaviour is not apparent for 
alginate concentration less than 5%. Theoretically, increasing the alginate concentration 
increases both the viscosity and stress for a specific value of shear rate [Rezende et al., 2009].  
3.5.2 Ageing of alginate solutions 
As mentioned in section 3.5.1, alginate solution tends to decrease in viscosity when the shear 
rate is increased. The study was prolonged for up to 4 weeks to see if there was any 
possibility that ageing could influence the viscosity of various alginate concentrations. As 
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seen in figures 3.3a, 3.3b, 3.3c and 3.3d, all of the alginate concentrations show decreased 
viscosity over 4 weeks. The most marked reduction was seen with the 5 % alginate 
concentration; while the others only decreased slightly. 
3.5.3 Degradation in different concentrations of alginate disc 
Figure 3.4 shows the dissolution process for an alginate disc up to 28 days in the 
supplemented media [Hunt et al., 2010]. The figure represents the dissolution pattern for all of 
the alginate concentrations and the process can clearly been seen from day 1 up to day 4 but 
then slows down by day 28. As mentioned in section 2.4, this can be explained by the 
presence of monovalent ions that compete with the Ca2+ ions. The high molecular weight of 
the alginate also contributes to the degradation process (section 2.10). When the alginate disc 
was highly concentrated, more Ca2+ ions are exchanged with the monovalent ions. As a 
consequence, the degradation process can be seen clearly when compared to the low 
concentration of alginate disc.  
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igure 3.3: Viscosity reduction of (a) 0.5%, (b) 1%, (c) 2% and (d) 5% alginate solutions up 
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Figure 3.4: Degradation of alginate discs of various concentrations up to 28 days. All of the 
alginate concentrations have a significant effect at each time points, except for day 2 and 3. 
Each result is the mean of three observations. Error bars represent standard deviations.   
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3.6 Discussion  
Viscosity is defined as resistance to flow [Barnes et al., 1989]. Less viscous solutions flow 
more easily when subjected to a shear stress [Barnes et al., 1989]. This can be seen when 
using a high concentration of alginate, (Figure 3.2a and 3.2b) when shear thinning is also 
observed. A possible explanation is because of the intermolecular association, known as 
entanglement, of the polymer chains being disrupted by application of shear stress [Barnes et 
al., 1989]. High viscosity may not be desirable in terms of maintaining cell viability before 
gel formation, as a high solution viscosity would lead to cells being exposed to high shear 
stress during mixing. Also, cell membranes are highly sensitive to shear stress, and the mixing 
can lead to cell death [Chisti 2001]. 
 
The ageing process has a greater effect at higher alginate concentration (5%) (Figure 3.3d) 
rather than at lower concentration (Figure 3.3a, Figure 3.3b and Figure 3.3c). This can be 
explained by molecular entanglement being higher in 5% alginate solution. As mentioned in 
section 2.10, if application of shear stress reduces entanglement, the effect will then be more 
noticeable at higher concentrations. Also, the storage temperature for the alginate solution 
contributes to this ageing process. This is shown in the viscosity study at two different 
temperatures, 37 °C (as shown in Figure 3.2a and 3.2b) and 25°C in Appendix A1. 
 
Gelation of alginate depends on the affinity of alginate or specifically the guluronic acid 
residues towards ions that bind to it [Draget et al., 1997]. In this study, the alginate that was 
used had a higher mannuroric than guluronic acid residue content and so will form a relatively 
weak gel in CaCl2 solution. As explained before, in section 2.4, it is known that alginate gel 
maintained in an aqueous environment, or specifically in tissue culture medium, has a 
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tendency to swell because of loss of crosslinking Ca2+ ions [Drury and Mooney 2003, Kuo 
and Ma 2008]. With regard to alginate concentration, higher polymer concentration may lead 
to a degradation tendency over time (swelling) because of the ability of alginate molecules to 
attract water [Drury and Mooney 2003, Kuo and Ma 2008]. As shown in figure 3.4, the 
degradation process can be clearly seen within 4 days in culture for all concentrations of 
alginate. Furthermore, with high intermolecular association, the swelling or degradation 
process takes longer. This explains why gel degradation can be seen more clearly at high 
concentration of alginate than at low concentration. 
 
By increasing the ionic binding, the mechanical rigidity of the gel could be enhanced but it 
could also lead to a greater concentration of counterions within the gel resulting in increased 
diffusion of water into the gel [Kuo and Ma 2008]. Furthermore, using a high concentration 
CaCl2 solution (100 mM) would be deleterious to the cells during the encapsulation process 
but no problem was observed in alginate that was rich in mannuronic acid residues [Simpson 
et al., 2004]. Indeed, for the past 20 years 100 mM CaCl2 solution has been used as a standard 
solution for alginate encapsulation and no deleterious effects have been reported. Low 
concentration CaCl2 solution tends to form a fragile gel. Also when there is a low 
concentration of CaCl2, the gel may degrade because there are few Ca2+ ions in it to replace 
those that diffused out. As stated in a previous study, a homogenous gelling process or slow 
cross-linking is essential to reduce the degradation process but these conditions are not 
suitable for cell encapsulation studies as they could have adverse effects on cell viability 
[Chisti 2001]. So, in the present study alginate with a high mannuronic acid content was used 
as this alginate was not sensitive to changes in the strength of the alginate gel network and 
tends to form spaces for the cells to grow into during the swelling or degradation processes 
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that occur in culture. This was supported by previous studies [Simpson et al., 2004, Wan et 
al., 2008] that showed that the strength of the alginate network also affects the growth of 
encapsulated cells. A weak alginate gel network is advantageous in tissue engineering 
constructs, or areas within a construct, when cell growth and expansion are required but not 
when they are not [Simpson et al., 2004].  
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4. EFFECT OF CALCIUM ALGINATE 
CONCENTRATION ON VIABILITY AND 
PROLIFERATION OF ENCAPSULATED 3T3 
MOUSE FIBROBLASTS 
4.1 Introduction 
There have been contrasting reports on the behaviour of certain cell types, such as fibroblast, 
βTC3 cells, hADAS cells, chondrocytes and bone marrow cells [Awad et al., 2004, Chia et 
al., 2005, Pokrywczynska et al., 2008, Simpson et al., 2004, Wang et al., 2003a] in alginate. 
For example, some authors report no significant change in cell numbers when compared to 
monolayer culture [Mosahebi et al., 2001], whereas others report proliferation and subsequent 
formation of agglomerates known as “spheroids” [Bartold and Page 1985]. The apparent 
variability of the reported cell behaviour may be attributed to a range of factors, including cell 
seeding density, alginate concentration and media type. Many researchers seed cells in 
alginate at densities of around 1 × 106 cells/ml [Choi et al., 2006, Iwashina et al., 2006, Lee et 
al., 2006, Pokrywczynska et al., 2008] but there has been little published work on modifying 
the alginate concentrations at specific cell densities. 
 
As explained in Chapter 3, an increase in the viscosity also increased the shear thinning 
behaviour and led to cells being exposed to high shear stresses during the mixing process. 
Consequently, this chapter presents the first detailed study of the influence of different 
alginate concentrations (and seeding densities on cell (section 4.3.3) viability, proliferation 
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and spheroid formation (section 4.3.4) for 3T3 fibroblasts. This was done to further elucidate 
the roles that these variables play in influencing 3T3 fibroblast behaviour when treated with 
PLIUS (Chapter 5)  
4.2 Materials 
Alginate (see section 3.2), Dulbecco’s Modified Eagle’s Medium (DMEM), 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) powder, and the DNAQF 
DNA Quantification Kit, were purchased from Sigma-Aldrich (Poole, Dorset, UK). Foetal 
calf serum was purchased from PAA Laboratories (Farnborough, Hampshire, UK) and the 
Live/Dead fluorescence assay kit (calcein AM and propidium iodide) was obtained from 
Invitrogen (Paisley, UK). All other materials that not mentioned here were obtained from 
Sigma-Aldrich.  
4.3 Methods 
4.3.1 3T3 mouse fibroblasts  
Fibroblasts were from a commercially available cell line (NIH 3T3 murine fibroblasts, ATCC, 
Middlesex, UK). Cells were maintained in DMEM supplemented with calf serum (10 v/v%), 
penicillin/streptomycin (1 v/v%), L-glutamine (2.4%), and HEPES (2-[4-(2-
hydroxyethyl)piperazin-1-yl]ethanesulfonic acid) (2.4 v/v%). Cells were stored in sterile 
conditions at 37ºC and 5% CO2 and media was refreshed every three days. 
4.3.2 Cell encapsulation 
Cells were detached from the flask in which they were cultured with trypsin (0.05%) and 
EDTA (0.2 g/l) and resuspended in DMEM. Viable cell numbers were determined by staining 
with trypan blue and counting in a haemocytometer, which is essential in quantification of the 
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growth properties of the cells [Freshney 2005]. After that, sodium alginate solutions (0.5, 1, 2, 
and 5 % made with double distilled water) were seeded with cells at low (0.76×105 cells/ml) 
and intermediate (0.76 × 106 cells/ml) densities. The cell suspension was transferred to the 
wells in twelve-well plates and incubated in a bath of sterile CaCl2 solution for 2 h [Khattak et 
al., 2006]. The resulting discs of calcium alginate with encapsulated cells were washed three 
times with sterile PBS (phosphate-buffered saline solution) and transferred to six-well plate; 
each well contained supplemented DMEM (5 ml) which was refreshed every 3 days. 
4.3.3. Live and Dead assay  
Fluorescence microscopy was used to examine fibroblasts encapsulated in calcium alginate. A 
slice of the construct (< 1.0 mm thickness) was incubated in DMEM (1 ml) with propidium 
iodide (25 µl, 150 µM) and calcein AM (2µl, 100 µM) for 30 min. It was then examined using 
a fluorescence microscope at 100× magnification (Axiolab, Zeiss, Oberkochen, Germany). 
Under these conditions, viable cells are green while dead cells (that contained propidium 
iodide) are red [Khademhosseini et al., 2006]. The percentages of viable cells (live/dead) 
were assessed from the photomicrograph obtained with a digital camera (Powershot G5, 
Canon, Tokyo, Japan) [Bunger et al., 2002]. The percentage of viable cells was measured 
every 4 days; all measurements were in triplicate. 
4.3.4 MTT assay 
The MTT assay was used to determine the number of viable cells in a sample; in this 
technique, living cells convert the MTT to formazan [Uludag and Sefton 1990]. MTT solution 
(5 mg/ml) was prepared in PBS (100 mM). MTT solution (500 µl) was added to the DMEM 
containing the encapsulated cells. The MTT was then left to stand for 20 h in an incubator at 
37ºC in an atmosphere containing 5% CO2 to allow for optimum formazan production 
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[Uludag and Sefton 1990]. The alginate discs were then removed from the wells and 
immersed in a solution of HCl in isopropanol (2 ml, 100 mM).  The alginate was then placed 
into a shaker incubator for 1 h to allow the formazan to fully diffuse from the disc into the 
solvent. The absorbance of the coloured solution was determined at a wavelength of 570 nm 
using a spectrophotometer (Cecil CE 1020, Cecil Instrument, Cambridge, UK) in order to 
determine the formazan concentration; absorbance measurements from discs without cells 
were subtracted from these results. The cell numbers were calculated from a standard curve of 
MTT concentration against cell number [Uludag and Sefton 1990]. The assays were 
undertaken at four day intervals and measurements were made in triplicate. 
4.3.5 Cell content 
Since the MTT assay is only known to be a reliable indicator of cell number when the samples 
compared exhibit identical metabolic rates, the results were validated using the Hoechst assay. 
Constructs, that had been cultured up to 10 days, were freeze-dried for 2 days, then digested 
in papain solution (1 ml; 125 µg/ml) [Hoemann et al., 2002]. Total cell numbers were 
determined by a Hoechst assay using a DNAQF DNA Quantitation Kit [Elder et al., 2006]. 
Hoechst 33258 dye (200 µl; 2 µg/ml) was added to samples (10 µl) in a 96 well plate. 
Fluorescence (excited at a wavelength of 360 nm) was measured using a spectrophotometer 
(Promega glomax, Promega, Southampton, UK) at a wavelength of 460 nm, at ambient 
temperature. The total cell numbers were obtained from a calibration curve of fluorescence 
intensity plotted against results from known densities (2.0–36.0 × 104 cells/ml) of 3T3 
fibroblasts cells. 
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4.4. Statistical analyses  
The Shapiro-Wilk test [Pallant 2007] showed that the results were not normally distributed. 
As a consequence results were compared using the Mann-Whitney and Kruskal Wallis tests 
[Pallant 2007]. Differences were considered to be significant if the probability p < 0.05; as 
shown in the figures, significant differences are marked with an asterisk. 
4.5 Results 
When seeded at a concentration of 0.76×106 cells/ml, at day 1, there were appreciable 
numbers of dead cells (Figure 4.1a) in the intermediate concentrations of alginates (5 and 2 
%) but not at the lower concentrations (1 and 0.5 %) (Figure 4.1b). However, the majority of 
cells appeared to be viable in the higher concentrations of alginate at day 16 and day 28. The 
cells appeared to grow in spheroids rather than being evenly dispersed thorough the gel; these 
spheroids can be clearly seen at day 28 (2 and 5 % concentrations of alginate) and day 16 (0.5 
and 1% concentrations of alginate). The tendency of the cells to grow in spheroids made it 
difficult to reliably count numbers from the micrographs. The first time-point at which the 
formation of these cell spheroids was noted appeared to be related to the concentration of 
alginate from which the gel was formed (Figure 4.2). When the gel was formed from 0.5% 
concentration alginate solution, for example, spheroid formation was noted after 8 days in 
culture, in comparison spheroid formation was not noted until after 20 days in culture in the 5 
% alginate gel (Figure 4.2).  
 
Quantitative results from fluorescence microscopy are shown in Figure 4.3. For cells 
encapsulated at a seeding density of 0.76×106 cells/ml, in 5 % alginate solution, only 50 ± 
4.5% (± standard deviation) of the original cells were shown to be viable one day after 
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establishing the culture and, in the case of the 2% alginate, 70 ± 4.0 % cells were shown to be 
viable after day one. In both of these conditions, cell viability was shown to improve to 
greater than 90% after only 4 days of culture (Figure 4.3a). Although there were significant 
differences between cell numbers in 5 and 2 % gels at day 12 and day 20, there was no 
consistent trend. In the case of the cells cultured in 0.5 or 1% of alginate solution, cell 
viability was greater than 90% (Figure 4.3b) after the first day of culture; however, with both 
of these gels, after 8 days of culture the gel discs start to soften in the medium.  
 
When the alginate gels were used to encapsulate cells at a lower concentration, the percentage 
alginate seemed to have a more marked influence on the viability of the encapsulated cells. 
After one day in culture, a proportion of cells fluoresced red in the Live/Dead assay indicating 
that the cells were dead (Figure 4.4). From the quantitative analysis, the influence of alginate 
concentration appeared to be significant on days 16, 20 and 28 in the 2% concentration 
alginate gel (Figure 4.5). Percentage of viable cells shows not much difference when using 
low (0.76×105cells/ml) and intermediate (0.76×106cells/ml) seeding cell densities (Figure 
4.6).  
 
To further quantify the influence of alginate concentration on cell number, cell number was 
also determined using the MTT assay (Figure 4.7). The results from the MTT assay further 
confirmed the observation that after 1 day of culture, in 5 % alginate, there were fewer viable 
cells. In the case of the 2% alginate, although cells were seeded at a density of 0.76×106 
cells/ml, after one day of culture, there were only 0.22×106 cells/ml actively metabolising. 
After four days in culture, cell number increased in all conditions. In 0.5% alginate, cell 
number was shown to increase 5 fold in a period of 4 days. For the remainder of the 
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experiment, cell number increased in all conditions, although cell number reached a plateau in 
the 2 % alginate after 20 days. Since the MTT assay can only be used as an indicator of cell 
number when the cells exhibit a constant metabolic rate, the Hoechst assay was used to verify 
cell number at days 1, 9 and 18. Cell number, as determined using the Hoechst assay at these 
time-points, was shown to be within 10% of that determined using the MTT assay (Figure 
4.8). 
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Figure 4.1: Fluorescence micrographs showing viable (green) and dead (red) cells in sections 
alginate discs for the intermediate seeding cells density (0.76×106 cells/ml). Micrographs were 
obtained after 1, 16 and 28 days for (a): 5 and 2%, (b) 1 and 0.5 % of alginate concentrations. 
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Figure 4.2: First day at which spheroid formation was detected. Specimens corresponding to 
the intermediate seeding density, were stained with propidium iodide and calcein AM and 
examined by fluorescence microscopy. 
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igure 4.3: Number of viable cells, measured by fluorescence microscopy from specimens 
ained with propidium iodide and calcein AM. Results are shown for the intermediate 
eding density of fibroblasts (0.76×106 cells/ml) in discs containing  (a) 5 and 2 % and (b) 1 
nd 0.5 % alginate concentrations. Each result is the mean of three observations. Error bars 
present standard deviations. Results that are significantly different (p < 0.05) are marked 
ith an asterisk.  
 
igure 4.4: Fluoresence micrographs showing viable (green) and dead (red) cells in sections 
f alginate discs for the low seeding cells density (0.76×105 cells/ml). Micrographs were 
btained after 1, 16 and 28 days. 
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Figure 4.5: Number of viable cells, measured by fluorescence microscopy from specimens 
stained with propidium iodide and calcein AM. Results are show for the low seeding density 
of fibroblasts (0.76×105 cells/ml) in discs containing 2 and 5% alginate concentrations. Each 
result is the mean of three observations. Error bars represent standard deviations.  Results that 
are significantly different (p < 0.05) are marked with an asterisk. 
 
Figure 4.6: Number of viable cells, measured by fluorescence microscopy from specimens 
stained with propidium iodide and calcein AM. Results are show for the low and intermediate 
seeding densities of fibroblasts in discs containing 2 and 5% alginate concentrations. Each 
result is the mean of three observations. Error bars represent standard deviations.  
 
Chapter 4  Viability and proliferation of 3T3 cells  
45 
 
 
Figure 4.7: MTT Assay with different concentration of alginate for the intermediate seeding 
density (0.76×106 cells/ml). Each result is the mean of three observations. Error bars represent 
standard deviations. Results that are significantly different (p < 0.05) are marked with an 
asterisk.  
 
 
Figure 4.8: Total cell numbers measured by the Hoechst 33258 assay at day 1, 9 and 18. Each 
result is the mean of three observations. Error bars represent standard deviations.  Results that 
are significantly different (p < 0.05) are marked with an asterisk. 
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4.6 Discussion 
For over 30 years, alginate has been used to encapsulate prokaryotic cells [Kierstan and 
Bucke 1977]. Since the early reports, it has been used as a scaffold for engineering tissues in 
vitro or for the delivery of cells in vivo [Eiselt et al., 2000]. This early work has led to 
research on the use of alginate to encapsulate a range of cell types. Although, on the whole, 
there is agreement that alginate provides a matrix in which cells can survive, different authors 
have reported contrasting cell responses to encapsulation. For example, some report the 
formation of cell spheroids within the alginate and, therefore, a continuous increase in cell 
number, whereas others report no significant change in cell number with time [Bartold and 
Page 1985, Mosahebi et al., 2001]. Here it was shown that the rate of cell proliferation and 
also the formation of cell spheroids within the scaffold material were dependent upon the 
concentration of alginate used to encapsulate the cells and also the density at which the cells 
were seeded into the scaffold material. At lower alginate concentrations (Figure 4.3b), there 
was a higher rate of cell proliferation than at comparatively higher concentrations (Figure 
4.3a). Furthermore there was a relationship between the first observation of cell spheroids 
within the scaffold and alginate concentration (Figure 4.2).  
 
Since chemically, the different concentrations of alginate are identical, it is likely that cell 
number was influenced by the mechanical confinement of the cells within the structure of the 
scaffold [Peirone et al., 1998]. In vitro, as the scaffold degrades there is little or no tissue 
ingrowth to reinforce the structure and consequently the alginate gel will become 
considerably weaker and will disintegrate [Drury and Mooney 2003, LeRoux et al., 1999]. 
Disintegration will remove the mechanical constraint of the matrix and enable cell 
proliferation. As mentioned in section 2.4, ionically cross-linked gels, such as alginate, 
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normally undergo dissolution at a rate that is influenced heavily by the localised ionic 
environment in which the scaffold is placed [Drury and Mooney 2003, LeRoux et al., 1999]. 
This phenomenon occurred more quickly at 0.5-1% alginate than in the range 2-5% and 
provides a possible explanation for the inverse relationship between the rate of cell [McConell 
et al., 2004] proliferation and alginate concentration.  
 
As stated in section 2.4, unmodified alginates do not encourage cellular interaction and caused 
the cells to form spheroids. Whether spheroid formation within the tissue engineering 
scaffolds is desirable or not depends on the application. For the formation of a homogeneous 
tissue structure, spheroid formation is not desirable since necrotic regions within the 
spheroids are formed probably due to insufficient nutrients and oxygen perfusion to their 
centre [McConell et al., 2004]. In other cases, however, the formation of spheroids in the 
hydrogel is a requirement for cell viability and for the maintenance of cellular phenotype 
[Yan et al., 2005, Yang et al., 2002]. In the case of hepatocytes, for example, alginate has 
been galactosylated in order to encourage spheroid formation and hence improved liver 
function [Yang et al., 2002]. Here, as the gel degraded with time in culture, more space would 
have been available that would have enabled the formation of cell spheroids (Figure 4.2). 
Previous work has noted that murine 3T3 fibroblasts mixed with alginate (1% concentration) 
at different high cells densities (2 × 106, 4 × 106 and 6 × 106 cells/ml) showed spheroid 
formation after two weeks in culture [Pokrywczynska et al., 2008]. Human foetal kidney 293 
cells encapsulated in 1.5% of alginate also formed spheroids after three weeks in culture 
[Read et al., 2001]. Whether or not spheroids form could also be determined by the 
proliferation rate of the encapsulated cell population. Rapidly proliferating cells have been 
shown to form spheroids more quickly than those that proliferate more slowly 
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[Pokrywczynska et al., 2008]. The findings presented in this thesis suggest that it is possible 
to control the cell spheroid formation process by modifying both the alginate concentration 
and the cell seeding density.  
 
In addition to the influence that the alginate gel has on cell characteristics, it is essential that 
the alginate exhibits sufficient mechanical integrity to make it sufficiently robust for clinical 
application. As the alginate concentration is increased, the alginate gel will become stiffer and 
more durable when immersed in culture medium. A compromise must be made, however, 
between mechanical properties and the effect that the viscosity of the alginate solution (before 
gel formation) can have on the viability of the encapsulated cells. As the concentration of 
alginate was increased to 2 and 5 %, there were a large proportion of dead cells found within 
the hydrogel matrix at day one (Figure 4.1a) as consequence of increasing the viscosity. A 
possible explanation is that the higher concentration solutions of alginate damage the cells. As 
explained in section 2.10 and Chapter 3, increase in viscosity will increase the resistant of a 
solution to flow. As a result, it will also increase the shear stress at the cell surface and so 
affect the cells when they are homogenised in alginate solution. 
  
Interestingly, although cell death in the gel matrix was apparent after one day of culture, the 
cell population appeared to recover quickly and levels of cell viability of >90% were reported 
in all conditions thereafter. This may suggest that the cells are able to rapidly proliferate into 
the spaces left by the dead cells in the alginate matrix, or that the propidium iodide based 
assay gave false positive results due to cell membrane damage that was insufficient to cause 
actual cell death.  
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5. PULSED-LOW INTENSITY ULTRASOUND 
STIMULATION OF 3T3 MOUSE FIBROBLASTS 
5.1 Introduction 
As described in section 2.8.2, the intensity of PLIUS is low enough to have minimal 
destructive effects on the treated area. Indeed, PLIUS does not harm cells because it has a low 
intensity and that the heating effect is negligible (appendix A2). This chapter is about PLIUS 
treatment of 3T3 mouse fibroblast encapsulated in alginate. The effect of PLIUS treatment on 
encapsulated cells supplemented with growth factors (ascorbic acid and TGF-β1) is also 
investigated.  
 
In this study, 3T3 mouse fibroblasts were cultured in alginate discs and the effect of PLIUS 
on cell number (measured by Hoechst 33258 assays), collagen synthesis (measured by 
hydroxyproline assays), and GaG content were evaluated. The spatial distribution of GaG 
deposition was determined using Alcian blue staining. SEM was used for observation of 
fibroblast morphology.  
5.2 Materials 
Alginate (see section 3.2), Dulbecco’s Modified Eagle Medium (DMEM), Alcian blue dye, 
chloramine T, 1,9 dimethylmethylene blue dye (DMB), p-dimethylaminobenzaldehyde (P-
DMBA), and a DNAQF DNA Quantification Kit, were purchased from Sigma-Aldrich 
(Poole, Dorset, UK). Foetal calf serum was purchased from PAA Laboratories (Farnborough, 
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Hampshire, UK). All other materials that not mentioned here were obtained from Sigma-
Aldrich.  
5.3 Methods 
5.3.3 Cell encapsulation 
3T3 fibroblasts were cultured accordance with the method in section 4.3.3. 
5.3.4 Encapsulated cells supplemented with growth factors 
Cells were cultured in accordance with the protocol in section 4.3.3, but some cultures were 
supplemented with 50µg/ml ascorbic acid [Neidert et al., 2002] and 2.5ng/ml transforming 
growth factor beta-1(TGF-β1) [Ross and Tranquillo 2003] to encourage extracellular matrix 
production. 
5.3.5 PLIUS treatment 
A Sonopuls 491 (Enraf-Nonius, Rotterdam, Amsterdam) ultrasound source was used (Figure 
5.1). Its transducer was immersed in a water bath filled with deionized water maintained at 
37°C [Doan et al., 1999] and treated with a chemical solution (Sigma Clean Water bath) to 
keep it free  from bacterial and fungal growth. The deionized water was changed every week. 
The six-well plate containing constructs to be treated was placed on top of the transducer; the 
control group was maintained in the same conditions without being exposed to ultrasound. In 
order to reach to a suitable treatment setting, PLIUS treatment on the cells were optimised  
using several different parameters (data not shown here). In this study, the ultrasound 
stimulation was performed 5 min everyday for 10 days at a frequency of 1 MHz and an 
intensity of 0.2 W/cm2 with a 20% duty cycle (i.e. 20 pulses were emitted in 1 s, so that each 
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pulse had a duration of 0.05 s). Treated and control samples were analysed, at regular 
intervals, to determine cell numbers, collagen content and GaG content. 
 
Figure 5.1: Ultrasound machine set up with the transducer immersed in the water bath at 
37°C. The encapsulated cells that maintain in six-well plate containing DMEM media and 
were placed on top of the transducer.  
 
5.3.6. Cell content 
The method to determine the total cell number of 3T3 mouse fibroblasts was described in 
section 4.3.5. 
5.3.7 Hydroxyproline assay (Method A) 
Collagen production was quantified using a hydroxyproline assay [Awad et al., 2004, Jamall 
et al., 1981] performed on samples cultured for 4, 6, 8 and 10 days. A suspension (500 µl) of 
the sample that had been digested with papain was hydrolyzed with HCl (12 M) at 110°C for 
20 h and then left in a vacuum incubator overnight to let all of the HCl evaporate [Reddy and 
Enwemeka 1996, Stegeman and Stalder 1967]. The samples were reconstituted in 50% 
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isopropanol with activated charcoal [Awad et al., 2004, Ross and Tranquillo 2003], then 
filtered through filter paper (QL100, medium/fast flow rate, Fisherbrand Loughborough, 
Leicestershire, UK). Chloramine-T solution and p-dimethylaminobenzaldehyde (P-DMBA) 
solution (Ehrlich's reagent) were sequentially added to each filtered sample. The optical 
densities of the samples were measured using a spectrophotometer (Cecil CE 1020, Cecil 
Instrument, Cambridge, UK) at a wavelength of 550 nm. The hydroxyproline content of the 
samples was determined from a regression line of absorbance plotted against concentration 
(0-12 µg/ml) for trans-4-hydroxy-L-proline.  
5.3.8 Hydroxyproline assay (Method B) 
A second method was used for the quantification of hydroxyproline content using a method 
previously described [Awad et al., 2004, Neidert et al., 2002, Stegeman.H and Stalder 1967] 
with some modification. This method was cheaper and less time-consuming for running the 
experiment when compared to the method in section 5.3.7. With this method, 50µl of papain 
digested samples were hydrolyzed in HCl (6 M) at 110°C for 20 h and then kept in the 
vacuum desiccator overnight to allow evaporation of the remaining HCl. The dried samples 
were then reconstituted with 200 µl assay buffer [5g/l citric acid (monohydrate), 12 g/l 
sodium acetate (trihydrate), 3.4g/l sodium hydroxide, and 1.2ml/l glacial acetic acid in 
distilled water, at pH 6.0 [Awad et al., 2004]. The reconstituted samples were then mixed 
with activated charcoal and left in ambient conditions for 30 min. The samples were then 
centrifuged at 14 000 rpm for 6 min. 50 µl of the clear samples were then mixed with 
chloramine T solution (62 mM) and then incubated at room temperature for 15 min to allow 
oxidation to occur. Then the samples were mixed with 50 µl (0.94 M) p-DMBA solution 
[Neidert et al., 2002] and incubated at 60°C for 30 min. The absorbance of the samples was 
measured at 550 nm using a microplate reader (Promega glomax, Promega, Southampton, 
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UK). The hydroxyproline contents of the samples were determined from a regression line of 
absorbance plotted against concentration (0-1 µg/ml) for trans-4-hydroxy-L-proline. 
5.3.9 Glycosaminoglycan (GaG) assay 
The GaG content was quantified by a previously described method [Enobakhare et al., 1996] 
with a slight modification. Briefly, 40 µl of papain digested samples were added to 250 µl 
DMB dye at pH 1.5. Absorbance was measured at 600 nm using a spectrophotometer. 
(Promega glomax, Promega, Southamton, UK). The GaG content of the samples was 
determined by calibrating the absorbance measurements using results from a standard solution 
of shark cartilage chondroitin 6 sulfate (0-100 µg/ml) from Sigma-Aldrich (Poole, Dorset, 
UK). 
5.3.10 Alcian blue staining 
Alginate discs containing cells were stained using Alcian blue dye [Shakibaei and DeSouza 
1997, Stevens et al., 2004]. The encapsulated cells were fixed with 10% formalin for 20 min 
then washed with PBS. The discs were then stained with Alcian blue dye for 48 h [0.05% 
Alcian blue in 3% acetic acid, pH 1.5 and 0.3M MgCl2] [Shakibaei and DeSouza 1997]. The 
alginate/cells were then washed sequentially with 3% acetic acid, 3% acetic acid and 25% 
ethanol, 3% acetic acid and 50% ethanol and 70% ethanol. The encapsulated cell were 
observed using a light microscope (Axiolab, Zeiss, Oberkochen, Germany) [Shakibaei and 
DeSouza 1997, Stevens et al., 2004]. 
5.3.11 Sample preparation for SEM 
3T3 mouse fibroblasts encapsulated in alginate disc were fixed with 2.5% glutaraldehyde in 
0.1M phosphate buffer for 1 h. After that the samples were dehydrated in alcohol (50%, 70%, 
90%, 100%) twice for 15 min for each respective alcohol change. Then the samples were 
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dried using critical point CO2 and the dried samples were mounted on a stub and coated with 
platinum. The samples were then viewed using scanning electron microscopy (Philips XL30 
ESEM FEG, Netherlands). 
5.4 Statistical analyses 
The Shapiro-Wilk test [Pallant 2007] for the normality test was done for all of the data 
presented here. The data were analyzed using the Independent t-test for normal data and 
Mann-Whitney test for non-normal data [Pallant 2007]. Differences were considered to be 
significant if the probability p < 0.05. 
5.5 Result 
5.5.1 Total cell number 
The total number of cells encapsulated in alginate was determined after 4, 6, 8 and 10 days of 
PLIUS treatment using the Hoechst 33258 assay. Using this method, PLIUS did not show any 
consistent effect on the number of encapsulated cells when compared to the control group 
(Figure 5.2 and Figure 5.3) or when supplemented with ascorbic acid and TGF-β1 (Figure 
5.4).  
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Figure 5.2: Cell proliferation study with intermediate seeding density (0.76×106 cells/ml) in 
control (Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each result 
is the mean of three observations. Error bars represent standard deviations. Results that are 
significantly different (p < 0.05) are marked with an asterisk. 
 
 
Figure 5.3: Cell proliferation study with high seeding density (2.0×106 cells/ml) in control 
(Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each result is the 
mean of three observations. Error bars represent standard deviations. Results that are 
significantly different (p < 0.05) are marked with an asterisk. 
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Figure 5.4: Cells proliferation study with high seeding density (2.0×106 cells/ml) and 
supplemented with growth factors (ascorbic acid and TGF-β1) in control (Ctrl) and treated 
group (PLIUS) after exposure with ultrasound in culture. Each result is the mean of three 
observations. Error bars represent standard deviations.  
 
5.5.2. Collagen content 
A hydroxyproline assay was undertaken to assess the ability of PLIUS to stimulate collagen 
production of the encapsulated cells. The experiments were done for two different seeding 
densities (0.76×106 cells/ml and 2.0×106 cells/ml) with two different medium conditions (with 
or without the growth factors). 
 
When seeded at 0.76×106 cells/ml, as shown in figure 5.5, the group treated with PLIUS 
appeared to produce collagen and reaches statistical significance (p < 0.05) at day 8 only. 
Consequently, the PLIUS effect at seeding density 0.76×106 cells/ml appears to be negligible. 
Chapter 5  PLIUS effect on mouse fibroblasts  
 
 
57 
 
At the higher cell density (2.0×106 cells/ml) (Figure 5.6) collagen production increased 
significantly (p < 0.05) for the treated group (PLIUS) at day 6 and day 10 in culture. 
It has been described in section 2.7 that growth factors (ascorbic acid and TGF-β1) are 
involved in collagen production. Here, (Figure 5.7), it shows that the hydroxyproline content 
of encapsulated cells (2.0×106 cells/ml) treated with PLIUS in a medium supplemented with 
growth factors (ascorbic acid and TGF-β1) appeared to increase the accumulation of collagen 
from day 4 to day 6 when compared to the control group. Comparing the total amounts of 
hydroxyproline with (Figure 5.7) and without the growth factors (Figure 5.5 and Figure 5.6), 
it seemed that encapsulated cells treated with growth factors and PLIUS might have more 
beneficial effect on increasing collagen content than the PLIUS alone on 3T3 fibroblasts.  
 
 
Figure 5.5: Hydroxyproline (Hyp) content by using Method A with intermediate seeding 
density (0.76×106 cells/ml) in control (Ctrl) and treated group (PLIUS) after exposure with 
ultrasound in culture. Each result is the mean of three observations. Error bars represent 
standard deviations. Results that are significantly different (p <0.05) are marked with an 
asterisk. 
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Figure 5.6: Hydroxyproline (Hyp) content by using Method A with high seeding density 
(2.0×106 cells/ml) in control (Ctrl) and treated group (PLIUS) after exposure with ultrasound 
in culture. Each result is the mean of three observations. Error bars represent standard 
deviations. Results that are significantly different (p <0.05) are marked with an asterisk. 
However, no significance value on day 8 (p = 0.05).  
 
Figure 5.7: Hydroxyproline (Hyp) content by using Method B with high seeding density 
(2.0×106 cells/ml) supplemented with growth factors (ascorbic acid and TGF-β1) in control 
(Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each result is the 
mean of three observations. Error bars represent standard deviations. Results that are 
significantly different (p <0.05) are marked with an asterisk. 
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5.5.3 Glycosaminoglycan (GaG) detection 
To further investigate the effect of PLIUS on the encapsulated cells, the DMB assay was 
undertaken to quantify GaG production for up to 10 days. The encapsulated cells (Figure 5.8 
and Figure 5.10) that were treated with PLIUS did not produce a significantly higher quantity 
of GaG when compared to the control at intermediate seeding density (0.76×106 cells/ml) and 
high seeding density (2.0×106 cells/ml) supplemented with ascorbic acid and TGF-β1. 
 
Encapsulated cells at a seeding density of 2.0×106 cells/ml (Figure 5.9) produced significantly 
higher GaG levels when compared to the control group after 10 days of treatment (p < 0.05). 
But the GaG levels did not vary markedly when compared to the control at days 4, 6 and day 
8. Furthermore, the results shown that PLIUS, alone (Figure 5.8 and 5.9) or in conjunction 
with the growth factors (ascorbic acid and TGF-β1) (Figure 5.10), shows a fluctuating pattern 
of stimulating the GaG productions. 
 
GaG accumulation in the encapsulated fibroblasts was examined using Alcian blue staining. 
On day 10, as shown in Figure 5.11, the stained sample showed the formation of 
proteoglycan- rich matrix around the fibroblast cells indicating the cells had begun to produce 
GaGs.  
 
Alcian blue staining revealed the accumulation of GaG for the whole experimental period. 
From these images, there are no clear difference in GaG production for control and treated 
(PLIUS) groups. 
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Figure 5.8: Glycosaminoglycan (GaG) content with intermediate seeding density (0.76×106 
cells/ml) in control (Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. 
Each result is the mean of three observations. Error bars represent standard deviations.  
 
 
Figure 5.9: Glycosaminoglycan (GaG) content with high seeding density (2.0×106 cells/ml) 
in control (Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each 
result is the mean of three observations. Error bars represent standard deviations.  Results that 
are significantly different (p < 0.05) are marked with an asterisk. 
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Figure 5.10: Glycosaminoglycan (GaG) content with high seeding density (2.0×106 cells/ml) 
supplemented with growth factors (ascorbic acid and TGF-β1) in control (Ctrl) and treated 
group (PLIUS) after exposure with ultrasound in culture. Each result is the mean of three 
observations. Error bars represent standard deviations. 
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Figure 5.11: Alcian blue staining of 3T3 mouse fibroblast encapsulated alginate aft
in culture. The blue dark surrounding the cells shows detection of GaG (arrow). (
Control and treated group with seeding density 2.0×106 cells/ml, (c): Alginate disc
and e) : Control and treated group with seeding density 2.0×106 cells/ml suppleme
growth factors. All micrograph are at the same magnification. 
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5.5.4 SEM 
Figure 5.2, 5.3 and 5.4, show that PLIUS has no effect on the viability/proliferation of 3T3 
mouse fibroblasts. This is probably due to lack of adhesion between 3T3 cells and alginate. 
This was confirmed by SEM images (Figure 5.12) which show floating/aggregation of cells 
encapsulated in alginate discs. Indeed, as explained in section 2.4.1, alginate does not interact 
with mammalian cells unless it is chemically modified. 
 
In this study, even without modification, alginate itself was able to maintain cell viability and 
enhanced collagen productions when treated with PLIUS alone (Figure 5.5 and Figure 5.6). 
Additionally, when the cells were encapsulated in alginate containing growth factors (ascorbic 
acid and TGF-β1) as shown in figure 5.7, the encapsulated cells show more collagen 
production than the cells encapsulated in alginate without growth factors (Figure 5.6). This is 
supported by a previous study; when transforming growth factor (TGF β) was tethered to 
PEG, (polyethylene glycol) it enhanced ECM of smooth muscle cell [Mann et al., 2001]. 
Furthermore, cells encapsulated with growth factor (ascorbic acid and TGF-β1) and treated by 
PLIUS exposure (Figure 5.7), produce more collagen than with PLIUS exposure alone 
(Figure 5.5 and 5.6). 
 
Nevertheless, this study shows that the cells still survive in alginate even without modification 
or growth factors.  
 
 
Chapter 5  PLIUS effect on mouse fibroblasts  
 
 
 
 
Figure 5.12: Scanning electron micrographs of a cr
mouse fibroblast cells encapsulated in alginate disc
the surface of alginate disc (arrow). (a): Control g
density 2.0×106 cells/ml, (c): Control group and (d): 
cells/ml supplemented with ascorbic acid and TGF-β
 
 b c d  e a 64 
oss section of alginate disc showing 3T3 
 after 10 days in culture. Viable cells on 
roup and (b): Treated group at seeding 
Treated group at seeding density 2.0×106 
1, (e): Alginate disc only. 
Chapter 5  PLIUS effect on mouse fibroblasts  
 
 
65 
 
5.6 Discussion 
The results presented here suggest that PLIUS has no appreciable effect on 3T3 fibroblasts 
proliferation. This finding was supported by a previous study by Miyamoto et al. (2005) who 
showed that bovine intervertebral disc cells encapsulated in alginate did not show any 
significant increase in cell number. However, there were also contradictory results that 
suggested that PLIUS can increase DNA synthesis (i.e. cell proliferation) in monolayers and 
when encapsulated [Doan et al., 1999, Iwashina et al., 2006]. Nevertheless, there are many 
factors that may influence these contradictory results. The PLIUS frequency and intensity, 
cell types and cell conditions that were used in the present study were totally different to those 
used in previous studies [Doan et al., 1999, Iwashina et al., 2006]. There is no suggestion, in 
the work reported here or any of the papers cited, that treating the cells with PLIUS decreases 
the number of cells, i.e. the cells are not harmed by treatment with ultrasound under these 
conditions.  
 
Still, ultrasound has proved to be beneficial in increasing ECM production. Therapeutically, 
non-thermal effects play a primary role in many previous findings. Specifically PLIUS or 
non-pulsed low intensity ultrasound stimulates collagen synthesis in fibroblasts [Doan et al., 
1999, Harvey et al., 1975, Ramirez et al., 1997, Reher et al., 1998, Tsai et al., 2006, Webster 
et al., 1980]. As in this study, the PLIUS treatment that has been used shows non-thermal 
effects (Appendix A2) and, as reported before, non-thermal effects can be divided into 
cavitation and acoustic streaming [Baker et al., 2001, Johns 2002, ter Haar 2007]. Previous 
work demonstrated that cavitation occurs when fibroblasts are exposed to PLIUS in vitro and 
stimulates collagen synthesis [Webster et al., 1980]. Contrary to the previous study, the non-
thermal effect in the present study involved none of these. As mentioned in Appendix (A2), 
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cavitation is a formation and collapsing microscopic bubbles that increases the temperature 
and causes damage or kills the cells [Johns 2002]. However, none of these phenomena appear 
to be seen in this study. As in Appendix A2, the temperature rise was low enough to be 
considered negligible and the cells also showed no damage (section 5.5.4) and also 
proliferated (section 5.5.1) when exposed to PLIUS.  
 
Indeed, treatment of fibroblasts, cultured in alginate gels, with PLIUS or in conjunction with 
growth factors (ascorbic acid and TGF-β1) increases collagen production. This conclusion is 
clear from comparison of results of total cell number studies and collagen production 
observations. Although treatment with PLIUS alone or with growth factor supplements 
(ascorbic acid and TGF-β1) does not have an appreciable effect on the numbers of cells, more 
collagen is produced by the treated (PLIUS with or without growth factors supplement) than 
the control group. This result can only be explained by treated cells producing more collagen. 
This result is consistent with observations on a range of cell types reported in the literature. In 
monolayer culture, there is an increase in collagen production on exposure to PLIUS [Doan et 
al., 1999, Reher et al., 1998, Tsai et al., 2006]. Moreover, cells in scaffolds also showed 
increased in collagen deposition when treated with PLIUS [Iwashina et al., 2006, Miyamoto 
et al., 2005, Schumann et al., 2006, Zhang et al., 2003].  
 
It has also been noted that conditions for ultrasound stimulation that lead to increased cell 
proliferation in monolayer culture may also reduce collagen production [Doan et al., 1999]. 
However, the negative effect on cellular proliferation following treatment with PLIUS on 
encapsulated cells has not been reported previously. The PLIUS treated group supplemented 
with growth factors (Figure 5.4) has fewer cells when compared with the PLIUS-treated 
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group alone (Figure 5.2 and Figure 5.3). However, the results of the treated group (PLIUS 
supplemented with growth factors) show more collagen production (Figure 5.7) than the 
results without the growth factor supplements (Figure 5.5 and Figure 5.6). It seems that 
fibroblasts, or specifically 3T3 fibroblasts, without growth factor supplements, are involved 
more in cell proliferation rather than in collagen production. 
 
This result was supported by previous findings that growth factors accelerate ECM 
accumulation [Bittencourt et al., 2009, Chojkier et al., 1989, Clark et al., 1995, Kim et al., 
2009, Neidert et al., 2002, Park et al., 2009, Ross and Tranquillo 2003]. In section 2.7, it was 
explained that ascorbic acid is important in functioning as a cofactor for collagen synthesis 
while TGF-β1 is involved in fibroblasts differentiating into myofibroblasts during wound 
healing. The results presented here show that the growth factors being used in this study have 
the effect of boosting collagen production with the aid of PLIUS.  
 
In the GaG study, the amount of GaG in the treated group (PLIUS with or without  growth 
factor supplements) showed no significant difference when compared to the control group 
(Figure 5.8 and Figure 5.10) and an apparently significant difference only after 10 days of 
treatment in figure 5.9 (PLIUS alone). As mentioned in a previous study [Enobakhare et al., 
1996], positive results in detection of GaG may be a result of interference by the alginate (as 
mentioned in section 2.9.2) if using DMB dye at pH 3.0. In this study, the interference was 
minimized by using the DMB dye at pH 1.5. [Chang et al., 2001]. However, Alcian blue 
staining (Figure 5.10) showed that the encapsulated cells produced GaG in culture.  
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As seen in SEM images, cells encapsulated within the alginate disc did not adhere to the 
surrounding molecules (Figure 5.12). However, the lack of cell adhesion that prevents cell 
spreading and proliferation is not necessarily detrimental to the cells (Figure 5.2, Figure 5.3, 
and Figure 5.4) since that the viable cells within the matrix can maintain their viability [Shih-
Feng et al., 2010]. Moreover, collagen production in this study shows an increase on exposure 
to PLIUS alone or in conjunction with growth factors. This finding showed that the cells are 
involved more in producing ECM when treated with PLIUS with or without the ascorbic acid 
and TGF β-1 but not in cell division.  
 
Treatment with PLIUS may be beneficial in tissue engineering for inducing fibroblasts to 
make stronger ECM perhaps leading to more effective tissue regeneration and repair. As 
explained before (section 2.2.1), ECM composition depends on the location of the cells that 
made them, resulting in different in their physical properties. Hukins and Aspden (1985) also 
mentioned that collagen reinforces ECM and, therefore, connective tissues leading, to 
increased stiffness and strength. Therefore, increased collagen production, as a result of 
ultrasound treatment, is likely to result in stronger tissues. It has been suggested previously 
that PLIUS, or therapeutic ultrasound generally, can enhance bone repair [Lirani-Galvao et 
al., 2006, Malizos et al., 2006], help in biological repair of intervertebral disc [Iwashina et al., 
2006] and shorten the time of cartilage formation in bioreactors [Hsu et al., 2006]. Collagen 
production can also be enhanced by TGF β1, insulin and ascorbic acid [Awad et al., 2003, 
Chojkier et al., 1989, Kim et al., 2009]. Physical stimulation with/without biochemical 
stimulation has shown a potential effect in stimulating collagen production without harming 
cell viability.  
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In future, studies on the effect of different PLIUS intensities on 3T3 mouse fibroblasts would 
be useful for understanding the specific conditions that can be beneficial to or harm cell 
viability/proliferation and ECM production. 
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6. PULSED –LOW INTENSITY ULTRASOUND 
EFFECT ON HUMAN DERMAL FIBROBLASTS 
6.1 Introduction 
Human dermal fibroblasts have been successfully used for treatment of sun-damaged-skin 
[Varani et al., 1994] and fetal skin repair [Lin et al., 1995]. Safe and non-invasive exposure 
using pulsed low-intensity ultrasound (PLIUS) may then be a useful method, alone or in 
conjunction with biochemical stimulation, for increasing ECM production and cell 
proliferation in dermatological applications. PLIUS could also be beneficial to improve 
wound healing for people suffering from diabetes mellitus, venous insufficiency and 
excessive pressure [Lai and Pittelkow 2007]. 
 
As described in Chapter 5, PLIUS was used to successfully stimulate collagen production by 
3T3 mouse fibroblasts. In this chapter, the work is extended to HDF cells.  
6.2 Materials 
The materials that used in this study were exactly the same as those described in sections 3.2 
and 5.2. 
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6.3 Methods 
6.3.1 Human dermal fibroblasts 
Fibroblasts were from a commercially available cell line (adult human dermal fibroblast 
(HDF), HPA Culture Collections, Porton Down, Salisbury, UK). Cells were maintained in 
DMEM supplemented with calf serum (10 v/v%), penicillin/streptomycin (1 v/v%), L-
glutamine (2.4%), and HEPES (2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid) (2.4 
v/v%). Cells were stored in sterile conditions at 37ºC and 5% CO2 and the media was 
refreshed every three days. 
6.3.2 Other methods 
All other techniques are described in the appropriate sections: cells encapsulation method 
(section 4.3.3), cell encapsulation method with growth factor supplements (section 5.3.4), 
PLIUS treatment (section 5.3.6), cell content measurement (section 4.3.5), hydroxyproline 
assay method B (section 5.3.7), glycosaminoglycan (GaG) assay (section 5.3.9), Alcian blue 
staining (section 5.3.10) and sample preparation for SEM (section 5.3.11). 
6.4 Statistical Analyses 
The analyses are described in section 5.4  
6.5 Results 
6.5.1 Total cell number  
To examine the total cell number for human dermal fibroblasts in alginate, the encapsulated 
cells were assayed using Hoechst 33258 dye after 4, 6, 8 and 10 days of PLIUS treatment. 
Throughout the experimental period, cells remained viable and showed proliferation in both 
groups (Figure 6.1 and 6.2). However, the group treated with PLIUS (Figure 6.1) showed 
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higher proliferation with a significant value at days 4 and 8 when compared to the control 
group.  
 
Figure 6.2, it shows that the control group has a significance difference ( p < 0.05) in culture 
supplemented with the growth factors (ascorbic acid and TGF-β1), when compared to the 
treated group, at day 6 only. From this result, it can be assumed that PLIUS treatment in 
conjunction with the growth factors (ascorbic acid and TGF-β1) did not stimulate the cells to 
proliferate more in culture.  
 
As shown in figure 6.1, up until 8 days of treatment, the treated group significantly increased 
by a factor of two (128×105 cells/ml) compared with the control group (83×105 cells/ml) in 
cell number. When both experiments were compared, as shown in figure 6.1 and figure 6.2, 
PLIUS treatment alone (treated group) represents better stimulation of the encapsulated HDF 
cells than when they were supplemented with the growth factors (ascorbic acid and TGF-β1). 
When comparing the cell number for the PLIUS treated group (Figure 6.1) with the PLIUS 
with growth factors (treated group) in figure 6.2, it can be seen that PLIUS alone stimulates 
cell proliferation by a factor of almost three (128×105 cells/ml) when compared with PLIUS 
with growth factors (45×105 cells/ml). In conclusion, supplementation with growth factors 
(ascorbic acid and TGF-β1) does not stimulate cell proliferation when combined with PLIUS.  
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Figure 6.1: Cell proliferation study with high seeding density (2.0×106 cells/ml) in control 
(Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each result is the 
mean of three observations. Error bars represent standard deviations. Results that are 
significantly different (p < 0.05) are marked with an asterisk.  
 
 
Figure 6.2: Cells proliferation study with high seeding density (2.0×106 cells/ml) and 
supplemented with growth factors (ascorbic acid and TGF-β1) in control (Ctrl) and treated 
group (PLIUS) after exposure with ultrasound in culture. Each result is the mean of three 
observations. Error bars represent standard deviations. Results that are significantly different 
(p < 0.05) are marked with an asterisk. 
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6.5.2. Collagen content 
This assay was done to assess the ability of PLIUS, alone or in conjunction with growth 
factors (ascorbic acid and TGF-β1), in stimulating collagen production in the encapsulated 
cells. The encapsulated cells that were treated with PLIUS alone showed a significant increase 
in hydroxyproline content ranging from 3.5µg to 6.7µg after 4 (p < 0.01), 6, 8 and 10 days (p 
< 0.05) of treatment (Figure 6.3).  
 
In contrast to the result in figure 6.3, the experiment in conjunction with the growth factors 
showed a fluctuating pattern (Figure 6.4) with hydroxyproline content ranging from 2.9 µg to 
5.8 µg, although this was only significant (p < 0.05) at day 6 for the whole experimental 
period. From these results, it appears that PLIUS alone is able to promote collagen production 
in HDF cells encapsulated in alginate.  
6.5.3 Glycosaminoglycan (GaG) detection 
The GaG content was quantified by the DMB assay. With this assay, the application of 
PLIUS alone has no significant effect on the treated group (Figure 6.5) for up to 10 days of 
treatment. When the growth media were supplemented with growth factors (Figure 6.6), a 
significant effect (p < 0.01) was obtained at day 8 but not at any other time, so there was no 
consistent significant result.  
 
GaG accumulation in the encapsulated HDF cells was examined by Alcian blue staining. 
After 8 days as shown in Figure 6.7, the stained sample showed halos of Alcian blue around 
the cells indicating that they had begun to produce GaGs. Alcian blue staining revealed the 
formation of GaGs for the whole experimental period. Although the results were qualitative, 
they showed no difference in GaG production for control and treated groups. 
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Figure 6.3: Hydroxyproline (Hyp) content with high seeding density (2.0×106 cells/ml) in 
control (Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each result 
is the mean of three observations. Error bars represent standard deviations. Results that are 
significantly different (p < 0.05,<0.01) are marked with an asterisk.  
 
 
 
Figure 6.4: Hydroxyproline (Hyp) content with high seeding density (2.0×106 cells/ml) 
supplemented with growth factors (ascorbic acid and TGF-β1) in control (Ctrl) and treated 
group (PLIUS) after exposure with ultrasound in culture. Each result is the mean of three 
observations. Error bars represent standard deviations. Results that are significantly different 
(p < 0.05) are marked with an asterisk. 
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Figure 6.5: Glycosaminoglycan (GaG) content with high seeding density (2.0×106 cells/ml) 
in control (Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each 
result is the mean of three observations. Error bars represent standard deviations.  
 
 
Figure 6.6: Glycosaminoglycan (GaG) content with high seeding density (2.0×106 cells/ml) 
supplemented with growth factors (ascorbic acid and TGF-β1) in control (Ctrl) and treated 
group (PLIUS) after exposure with ultrasound in culture. Each result is the mean of three 
observations. Error bars represent standard deviations. Results that are significantly different 
(p < 0.01) are marked with an asterisk. 
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Figure 6.7: Alcian blue staining of human dermal fibroblast encapsulated alginate 
days in culture. The blue dark surrounding the cells shows detection of GaG (arrow).
b): Control and treated group with seeding density 2.0×106 cells/ml, (c): Alginate disc 
and e) Control and treated group with seeding density 2.0×106 cells/ml supplemente
growth factors. All micrograph are at the same magnification. 
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6.5.4 SEM 
As shown in figure 6.8, there were no apparent damage to the cells for the PLIUS treated 
group when compared to the control group. These results are the same as for the 3T3 cells in 
section 5.5.4. Indeed, the cells did not spread, into a fibroblast-like shape because alginate is 
lacking in cell attachments. However, this does not appear to be a detrimental effect because 
the HDF cells maintained their viability and proliferated in culture.  
6.6 Discussion 
Many previous studies have shown a positive effect of therapeutic ultrasound, at different 
doses, on different types of human fibroblasts [Doan et al., 1999, Harvey et al., 1975, Lai and 
Pittelkow 2007, Reher et al., 1998, Wang et al., 2003b, Webster et al., 1980]. However, 
previous studies were all performed on monolayers of cells; this is the first study that the cells 
were maintained in 3D culture.  
 
It is clear from the results presented here that therapeutic doses of PLIUS have a positive 
effect on HDF cells. With or without growth factors, the treated cells proliferate for up to 10 
days of treatment (Figure 6.1 and Figure 6.2). This finding is supported by previous studies 
that showed that therapeutic ultrasound increased the cell numbers for human fibroblasts 
[Doan et al., 1999, Reher et al., 1998, Wang et al., 2003b]. As discussed in the previous 
chapter, PLIUS does not stimulate the proliferation of 3T3 cells. However, in the case of HDF 
cells, the results presented in this chapter show that PLIUS did stimulate cell proliferation. 
This might be due to the different source of the fibroblasts that were being exposed to PLIUS. 
Doan et al. (1999) stated that if the cell numbers increased because of PLIUS treatment; this 
could be interpreted as a deleterious effect because the cells are involved in cell division but 
not in matrix production.  
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However, the data presented here were not totally in agreement with the results of Doan et al. 
(1999). 
 
As shown in figure 6.3, the hydroxyproline content increased for up to 10 days of treatment 
but when the cells were supplemented with growth factor (Figure 6.4) the results show a 
fluctuating pattern. As discussed in Chapter 5, 3T3 cells treated with PLIUS and a growth 
factor supplement (ascorbic acid and TGF-β1) produced more collagen (Figure 5.7) than the 
control group. However, HDF cells maintained in culture supplemented with growth factor 
(Figure 6.4) show no increase in hydroxyproline when treated with PLIUS. It is well known 
that growth factors function by accelerating matrix accumulation and show positive effects to 
many types of cells [Bittencourt et al., 2009, Chojkier et al., 1989, Clark et al., 1995, Kim et 
al., 2009, Neidert et al., 2002, Park et al., 2009, Ross and Tranquillo 2003] However, the 
results presented in this chapter are inconsistent with these published observations. This may 
have been due to the type of cells and scaffold being used, and the culture conditions to 
maintain the cells [Bittencourt et al., 2009, Chojkier et al., 1989, Clark et al., 1995, Kim et 
al., 2009, Neidert et al., 2002, Park et al., 2009, Ross and Tranquillo 2003]. Furthermore, this 
study involved exposure to PLIUS but the cited studies did not use any physical stimulation to 
enhance ECM accumulation.  
 
Treatment with PLIUS alone appeared to have no effect on GaG production (Figure 6.5) but 
shows a significant result (3.2 mg/construct) only at day 8 when in conjunction with growth 
factors (Figure 6.6) but not at other times during the experimental period.  
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Nevertheless, Alcian blue staining (Figure 6.7) showed that the HDF cells/alginate construct 
produced GaG with or without the growth factor supplements. The results were very similar 
to those described for 3T3 cells in Chapter 5.  
 
SEM shows that cells encapsulated within an alginate disc did not adhere to the surrounding 
alginate (Figure 6.8). This was supported by previous studies showing that cells did not 
adhere to the alginate gel [Augst et al., 2006, Lee and Mooney 2001] unless the alginate was 
chemically modified [Augst et al., 2006, Rowley et al., 1999]. 
 
Furthermore, alginate is a highly porous material and so is likely to entrap cells within the 
matrix rather than their adhering to the alginate molecular chains [Shih-Feng et al., 2010]. 
However, lack of cell adhesion did not prevent the HDF cells proliferating, even though the 
cells did not attach to the alginate (Figure 6.1 and Figure 6.2). Moreover, the collagen content 
also increased significantly for the whole experimental period as a result of PLIUS treatment 
alone (Figure 6.3) but not when it was combined with growth factors (Figure 6.4).This shows 
that the cells can produce more collagen when treated with PLIUS alone.  
 
It is noteworthy that, under the conditions used in these experiments, PLIUS treatment did not 
show any deleterious effect on the cells. This is consistent with recent work in which PLIUS 
with a frequency of 1 MHz and intensities in range of 0.75 to 1mW/cm2 with 10% -20% duty 
cycles did not inhibit cell viability and proliferation [de Oliveira et al., 2008, Doan et al., 
1999, Ramirez et al., 1997, Reher et al., 1998, Wang et al., 2003b]. Indeed, there is a 
possibility that the PLIUS conditions used in this experiment could be beneficial in wound 
healing [Lai and Pittelkow 2007] and dermatological applications. 
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7. EFFECT OF PULSED-LOW INTENSITY 
ULTRASOUND EXPOSURE ON CALF 
CHONDROCYTES  
 
7.1 Introduction 
Articular cartilage possess little capacity for self-repair, after being damaged by disease or 
trauma, due to the low mitotic activity of its cells [Hsu et al., 2006, Hunziker 2002, Zhang et 
al., 2003]. This low mitotic activity can potentially be ascribed to the low metabolic and 
biosynthetic activities of mature chondrocytes and, at least in part, to the lack of chondrogenic 
cells available for repair [Buckwalter and Mankin 1997, Fragonas et al., 2000]. This is 
because articular cartilage is not similar to many other connective tissue, because it is 
avascular, aneural and has no lymphatic system. As a consequence, nutrients and waste 
products are delivered through diffusion process by pumping action that occurs during 
compression of cartilage [Furukawa et al., 2008, Maroudas 1976].  
 
In spite of the extensive published studies documenting the response of chondrocytes to 
PLIUS treatment [Hsu et al., 2006, Parvizi et al., 1999, Zhang et al., 2003], in this chapter the 
exact conditions that have been used to treat 3T3 mouse fibroblasts (Chapter 5) and human 
dermal fibroblasts (Chapter 6) were used to test the effects on calf chondrocytes.  
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7.2 Materials 
The materials that used in this study were exactly the same as those described in sections 3.2 
and 5.2 except for the DMEM media from Invitrogen (Paisley, UK). 
7.3 Methods 
7.3.1 Calf chondrocytes  
Chondrocytes were isolated from calf articular cartilage (a generous gift from Professor 
Charles Archer, Cardiff School of Bioscience, University of Cardiff). Cells were maintained 
in DMEM supplemented with calf serum (10 v/v%), gentamycin (0.1v/v%), HEPES (2.4%) 
and 50µg/ml ascorbate. Cells were stored in sterile conditions at 37ºC and 5% CO2 and the 
media was refreshed every three days. 
7.3.2 Other methods 
All other techniques are described previously in appropriate sections. They are: the cell 
encapsulation method (section 4.3.3), PLIUS treatment (section 5.3.6), cell content study 
(section 4.3.5), hydroxyproline assay method B (section 5.3.7), glycosaminoglycan (GAG) 
assay (section 5.3.9), Alcian blue staining (section 5.3.10) and sample preparation for SEM 
(section 5.3.11). 
7.4 Statistical analyses 
The analyses same as described in section 5.4 and 6.4. 
7.5 Results 
The viability/proliferation of chondrocytes in the 3D alginate culture for both groups (control 
and PLIUS) shows a fluctuating pattern with the total cell number in the range 17 - 39 ×105 
Chapter 7  PLIUS effect on calf chondrocytes  
 
 
84 
 
cells/ml for the control group and 27 - 47 ×105 cells/ml for PLIUS group (Figure 7.1). At no 
time period was there a significant different between treated and control groups. 
 
The hydropxyproline assay (Figure 7.2) shows that PLIUS may have a tendency to enhance 
collagen production in the treated group. It appears to be significant on day 4. However, there 
is no evidence for PLIUS consistently enhancing collagen production for encapsulated calf 
chondrocytes. 
 
GaG content was quantified using the DMB assay. With this assay, PLIUS treatment for 10 
days in culture did not represent any significant effect in increasing GaG production (Figure 
7.3). The graph itself shows a decreasing amount of GaG with time.  
 
Alcian blue staining was done to confirm GaG accumulation around the encapsulated 
chondrocytes. After 8 days, as shown in Figure 7.4, the stained sample showed halos of 
Alcian blue around the cells indicating GaG production. Alcian blue staining revealed the 
formation of GaG for the whole experimental period. However, the results represent only 
qualitative detection; they showed no difference in GaG production for control and treated 
groups. 
 
Figure 7.1 shows that PLIUS did not have any effect on chondrocyte viability and 
proliferation. When observed in SEM micrographs, the cells showed no differences when 
compared to the control group. However, the chondrocytes encapsulated in alginate had a 
rounded chondrocyte-like appearance (Figure 7.5). This was supported by previous findings 
that also show that chondrocytes maintain their rounded morphology in 3D culture 
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[Bittencourt et al., 2009, Loty et al., 1998, McConell et al., 2004] but have a spread, 
fibroblast-like, shape in 2D culture (i.e., in a monolayer) [Bittencourt et al., 2009, Loty et al., 
1998, McConell et al., 2004]. It appears that chondrocytes maintain a rounded morphology 
when encapsulated in alginate while fibroblasts do not maintain their fibroblast-like shape 
when encapsulated in alginate gels (section 5.5.4 and section 6.4.4).  
 
 
 
 
Figure 7.1: Cell proliferation study with high seeding density (2.0×106 cells/ml) in control 
(Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each result is the 
mean of three observations. Error bars represent standard deviations. 
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Figure 7.2: Hydroxyproline (Hyp) content with high seeding density (2.0×106 cells/ml) in 
control (Ctrl) and treated group (PLIUS) after exposure with ultrasound in culture. Each result 
is the mean of three observations. Error bars represent standard deviations. Results that are 
significantly different (p < 0.05) are marked with an asterisk. 
 
 
 
Figure 7.3: GaG content with high seeding density (2.0×106 cells/ml) in control (Ctrl) and 
treated group (PLIUS) after exposure with ultrasound in culture. Each result is the mean of 
three observations. Error bars represent standard deviations.  
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Figure 7.4: Alcian blue staining of calf chondrocytes encapsulated in alginate after 8 days in 
culture. The blue dark surrounding the cells shows detection of GaG (arrow). (a and b): 
control and treated group with seeding density 2.0×106 cells/ml, (c): alginate disc only. All 
micrographs are at the same magnification. 
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7.6 Discussion 
The aim of this study was to determine whether the PLIUS conditions used in this thesis can 
increase cell proliferation, enhance collagen production and stimulate GaG production. 
Previous studies have reported that PLIUS promotes cell proliferation [Hsu et al., 2006, 
Zhang et al., 2003] and matrix deposition by chondrocytes in 3D culture systems [Hsu et al., 
2006, Parvizi et al., 1999, Zhang et al., 2003]. 
 
Here it is shown that the PLIUS conditions used in this study did not promote chondrocyte 
proliferation in culture. The total cell numbers appear to fluctuate during the 10 days of the 
study. Previous studies showed no proliferation of chondrocytes when cultured in an alginate 
matrix [Chia et al., 2005] and Parvizi et al. (1999) reported no proliferation of chondrocytes 
when treated with PLIUS in a 2D culture system. There is no previous study of chondrocytes 
cultured in alginate that have been exposed to PLIUS, with the same dose used in the present 
study. From the results presented here, it can be concluded that PLIUS exposure has no effect 
in stimulating chondrocyte proliferation when cultured in alginate matrix. 
 
A possible explanation, for this result, is that the alginate matrix is limiting the mass transfer 
of essential nutrients through the gel [McConell et al., 2004]. As a result, the supply of 
nutrients becomes low and the cell population stabilizes (i.e., maintenance of viability without 
proliferation). However, a previous study reported that chondrocyte cell numbers increase 
when they are seeded in alginate with a low seeding cell density (1×104 cells/ml) [Gagne et 
al., 2000]. This might be another reason why the chondrocytes in the present study did not 
show any proliferation in culture. Furthermore, Zhang et al. (2003) stated that PLIUS 
influenced chondrocyte proliferation in an alginate matrix in an intensity-dependent manner, 
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which means there is a possibility that the PLIUS intensity used in present study was not 
suitable to promote chondrocyte proliferation. A previous study also reported that the buffer 
system for culturing chondrocytes in an alginate matrix also plays an important role [Xu et 
al., 2007]. According to their observations, supplemented DMEM with HEPES and 
bicarbonate buffer improves chondrocytes growth and matrix production in 3D alginate 
beads. In the present study, DMEM was supplemented only with HEPES buffer and this may 
be another reason for low cell proliferation and low collagen and GaG production.  
 
Collagen production only showed a significant difference at 4 days of PLIUS treatment. Since 
that it only appear once for the whole experimental period, it can be considered PLIUS has no 
effect in stimulating collagen production. 
 
GaG detection also shows no difference between control and PLIUS-treated groups for the 
whole experimental period. As discussed in the previous chapters (section 5.5.3 and section 
6.4.3), there was a decrease in the amount of GaG produced, with time in culture, for the other 
cell types investigated in this thesis. Also, comparing the control and the PLIUS-treated 
group, there was no significance difference in GaG accumulation. Alcian blue staining 
showed qualitatively that GaGs accumulated around the cells [Chia et al., 2005] in alginate 
discs.  
 
SEM micrographs show a spherical morphology [Hsu et al., 2006, Noriega et al., 2007] for 
chondrocytes when cultured in alginate discs and no damage to the cells after exposure to 
PLIUS when compared to the control group. The cells did not proliferate in alginate when 
treated with PLIUS and there was no defect/injury to the cells seen in the SEM micrographs. 
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In the literature, TGF-β1 was reported to be able to stimulate collagen and GaG biosynthesis 
by chondrocytes in 2D culture [Redini et al., 1988]. However, in this study there was only 
PLIUS exposure (physical stimulation) and no growth factor/biochemical stimulation 
involved. Another study showed that TGF-β1 did not stimulate collagen and GaG synthesis in 
3D culture in agarose [Skantze et al., 1985].  
 
As mentioned in section 2.6.2, chondrocytes are reported to require a 3D scaffold in order to 
maintain their morphology [Bittencourt et al., 2009] and that, when they are cultured in 
alginate hydrogel, they increase in number and viability as well as showing increased GaG 
synthesis [Bittencourt et al., 2009, Chia et al., 2005]. In the present study, there was no 
significant chondrocyte proliferation (Figure 7.1), collagen production (Figure 7.2) and GaG 
production (Figure 7.3) in alginate when exposed to PLIUS. A possible reason for this 
behaviour is that the kind of alginate [Domm et al., 2004] used might be different in different 
studies but the exact reasons for the conflicting findings is still unclear. 
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8.  OVERALL CONCLUSIONS 
This thesis is aimed at investigating the effect of PLIUS on the viability/proliferation of 
different types of cells (3T3, HDF and calf chondrocytes) and their ability to produce ECM. 
As mentioned in Chapter 1, the original work is covered in five different chapters. The study 
begins by investigating the different concentrations of alginate solution (0.5, 1, 2, and 5%) in 
Chapter 3. Chapter 4 is about the effect of different alginate concentrations with different 
seeding densities on the viability/proliferation of 3T3 cells. After deciding on a suitable cell 
seeding density and the matching alginate concentration, the study continues with PLIUS 
treatment of encapsulated 3T3 cells in Chapter 5, HDF cells in Chapter 6 and, in Chapter 7, 
the study was extended to calf chondrocytes since many previous studies reported that 
treatment with therapeutic ultrasound caused chondrocytes to produce more collagen in 
culture [Hsu et al., 2006, Parvizi et al., 1999, Zhang et al., 2003]. 
 
Chapter 3 describes the alginate properties. This chapter focuses on the viscosity, ageing and 
degradation of alginate solutions with different concentrations. In this chapter, it is shown that 
alginate solutions with higher concentrations had a high viscosity and consequently this 
would increase the shear stress applied to cells by the solution during mixing. An ageing 
process for the alginate solution was also clearly apparent for the higher concentration 
alginate (5%) but less so for the lower concentration alginate solutions. The degradation study 
in this chapter showed that when the alginate concentrations increased, the degradation 
process occurred slowly and took longer than at the lower alginate concentrations. From this it 
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can be concluded that 5% and 0.5% concentration alginate is not a suitable concentration as a 
medium to encapsulate the cells.  
 
Chapter 4 focused on the viability and proliferation of 3T3 cells when encapsulated in 
different concentrations of alginate solution. Sections 2.4 and 2.5 explain, in detail, why 
alginate was chosen as a scaffold material. In summary, it is easily gelled when seeded with 
cells, it is biocompatible and it resembles the GaG gel that occurs in ECM [Rowley et al., 
1999, Wang et al., 2003a]. As described in Chapter 4, the viability of 3T3 cells decreased 
when higher concentration alginate solutions were used; this could be explained by 
concentrated alginate solutions exerting a high shear stress at the cell surface, when the cells 
were dispersed before gelation, which could have damaged the cells (see section 3.5.1). Also 
in this chapter, spheroid formation occurred during cells proliferation. This can be seen 
clearly at lower concentration of alginate solutions and may arise because alginate lacks a cell 
attachment site, unlike ECM. 
 
In Chapter 5, PLIUS was applied to 3T3 encapsulated cells to stimulate them to produce more 
collagen in culture. PLIUS alone stimulated collagen production by 3T3 cells. PLIUS with 
growth factor supplements showed more collagen production by the encapsulated cells at 
early experimental periods. GaG detection shows no difference between the treated and 
control groups. SEM micrographs show no damaged to encapsulated cells when treated with 
PLIUS. From this, it can be concluded that PLIUS treatment of 3T3 cells did not harm the 
cells and can stimulate collagen production alone or in conjunction with growth factor 
supplements.  
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Since positive effects were seen when the 3T3 cells were treated with PLIUS, it was decided 
to extend the study to include another type of fibroblast (HDF) in Chapter 6. For the 
proliferation study of HDF cells encapsulated in alginate, it appeared that PLIUS alone can 
stimulate cell proliferation. In the collagen production study, PLIUS alone stimulated 
collagen production of HDF encapsulated cells more than PLIUS treatment with growth 
factor supplements. PLIUS alone or with growth factor supplements showed no effect on GaG 
accumulation when compared to the control group. SEM images also did not show any 
damaged or injury to the HDF encapsulated cells after being treated with PLIUS alone or with 
growth factor supplements. It is concluded that fibroblasts from different sources can show 
different results when exposed to PLIUS. Furthermore, PLIUS alone was able to stimulate 
collagen and cell proliferation on HDF cells. This study suggests that PLIUS could be used as 
a physical stimulation tool for treating skin problems by tissue engineering.  
 
In the previous chapters (Chapter 5 and Chapter 6), PLIUS showed a positive effect on 3T3 
and HDF cells, when applied at the frequency and intensity chosen for this study. In Chapter 
7, PLIUS treatment of calf chondrocytes was investigated since previous studies have 
reported that PLIUS has a positive effect on cartilage at the cellular level [Hsu et al., 2006, 
Parvizi et al., 1999, Zhang et al., 2003]. However, in this study, PLIUS did not show any 
stimulation effect in the viability/proliferation study and in collagen and GaG production 
when cultured in alginate. As reported before, chondrocytes need to be cultured in 3D, to 
make them maintain their rounded morphology, in order to produce ECM and regenerate 
cartilage in vitro [Choi et al., 2006, Hsu et al., 2006, Langer and Vacanti 1993]. 
Consequently, it can be concluded that PLIUS , as used in this study, was not suitable for 
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increasing cell proliferation and stimulating ECM production, even though chondrocytes were 
cultured in 3D. 
 
In conclusion, this thesis describes a series of studies on characterising alginate behaviour, 
cell viability study in different alginate solutions and PLIUS treatment on different cells type. 
The results from these tests have shown how different types of cells respond to PLIUS 
treatment. It should be possible to apply PLIUS (with the frequency, intensity and duty cycle 
used in the present study) to investigate further effects in tissue engineering applications.  
 
Further studies can be done using different type of biomaterials (scaffolds) or a mixture of 
two or more different kind of materials to make the scaffold more durable in culture and at the 
same time support cell growth and encourage the cells to produce more ECM. When it is 
necessary, the scaffold can degrade as it is replaced by new tissue [Jones 2005, Wang et al., 
2003a]. 
 
In this study PLIUS treatment was only done at one frequency, intensity and duty cycle. 
Future studies may attempt to vary the frequency, intensity or duty cycle and this may 
produce different results than those presented in this study and could promote the cells to 
produce more ECM.  
 
Finally, all of the cells that were used in this study are differentiated. Further studies could 
attempt to use mesenchymal stem cells. This is also another path for the application of 
PLIUS, to see if it can induce differentiation of stem cells to produce specific cells type in 
culture. 
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APPENDIX 
A1 Viscosity measurements 
 
 
Figure A1.1: Viscosity variation on different alginate solutions at temperature 25°C. 
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A2 Ultrasound characterization 
A2.1 Introduction 
As mentioned in section 2.9, ultrasound is a mechanical vibration in form of sound wave with 
frequency > 20 kHz and frequencies in the range 0.8 to 3 MHz are usually used for 
therapeutic applications [Cambier et al., 2001, Wu and Nyborg 2006]. The absorption of a 
sound wave results in molecular movement, i.e. heat that causes a temperature rise if it is not 
dissipated [Cambier et al., 2001]. The phenomenon of cavitation can also contribute to the 
temperature rise; it happens when gas-filled bubbles in the tissue fluids expands and compress 
rapidly [Johns 2002, Speed 2001]. These rapid changes both in and around the cells may 
cause damage to them [Johns 2002, Speed 2001]. However, if the heat is dissipated, any 
effects of the ultrasound are expected to be non-thermal. 
 
It is believed that non-thermal effects can occur at low intensities or with a pulsed output of 
ultrasonic energy [Cambier et al., 2001]. It also proposed that non-thermal effects can 
stimulate fibroblast activity, increase protein synthesis, increase blood flow, increase tissue 
regeneration and stimulate bone healing [Speed 2001]. Indeed, a previous study reported that 
non-thermal effects of pulsed low-intensity ultrasound stimulated bone formation with no 
temperature rise at a power output of 0.1 W/cm2 [Reher et al., 1997].  
 
The purpose of this study was to investigate the temperature rise with the setting that has been 
chosen (1MHz, 0.2 W/cm2, 20% duty cycle (i.e. 20 pulses were emitted in 1 s, so that each 
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pulse had a duration of 0.05 s) for 5 min). This is important to understand how ultrasound 
affects encapsulated cells in culture.  
A2.2 Methods 
A2.2.1 Sonopuls 491 characterization 
The same ultrasound source (Sonopuls 491, Enraf-Nonius, Rotterdam, Amsterdam) was used 
in all the experiments described in this thesis. The current experiment was done in conditions 
that resembled, as closely as possible, those used in the encapsulated cell studies. To 
investigate temperature rise, the ultrasound transducer was immersed in a water bath filled 
with deionized water maintained at 37°C [Doan et al., 1999] that was treated with Sigma 
Clean Water Bath (50 ml, Sigma-Aldrich, Poole, Dorset, UK) to keep it free from bacterial 
and fungal growth. The water was changed every week. A beaker containing 5 ml water 
covered with parafilm, to minimise heat losses by convection, that had been kept overnight in 
an incubator at 37°C, was put on top of the transducer with the bottom of the beaker at a 
distance of  approximately 1-2 cm from the transducer. A thermometer (Scientific Laboratory 
Supplies, Wilford, Nottingham, UK) with a range from -55.0°C to 148.8°C with a resolution 
0.1°C was immersed in the beaker and the parafilm cover retained to reduce heat loss. The 
pulsed low-intensity ultrasound setting was applied for 5 min at 1 MHz, 0.2 W/cm2 with a 
20% duty cycle (i.e. 20 pulses were emitted in 1 s, so that each pulse had a duration of 0.05 s 
for 5 min). The experiment was done 3 times to measure the temperature increase.  
A2.3 Statistical analyses 
There was a weak but significant (R=0.97, p= 0.002) linear correlation (regression) between 
temperature (°C) and time (min) in which temperature, T, was related to time, t, by T=33.9 
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+0.0809t. This calculation was done using the Minitab Package (version 15, Minitab Ltd, 
Coventry, UK). 
A2.4 Results 
A2.4.1 PLIUS treatment 
Figure 4.1 shows the temperature rise during the PLIUS exposure. As seen from the graph, 
the starting temperature of the experiment was at 33.9°C not 37°C. This probably arose from 
heat loss during inserting the thermometer probe in the beaker. However, the results show that 
the temperature increased only about 0.3°C for the whole 5 min exposure. 
 
 
Figure A2: Temperature increase resulting from the ultrasound exposure as described in the 
text. Each result is the mean of three observations. Error bars represent standard deviations.  
 
A2.5 Discussion 
Cavitation could cause damage when living cells are treated with ultrasound; it involves the 
expansion of microscopic gas bubbles that lead to large temperature rises within and around 
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the cells. However, direct measurement on the surface or micro-environment of the cells are 
currently not possible [Johns 2002].  
 
In the experiment described here, the temperature increased only 0.3°C over 5 min with the 
setting that been used to investigate the effect of ultrasound on cells (see Chapters 4, 5, 6). 
Previous studies by Johns (2002) and Reher et al.(1997) also demonstrated that temperature 
increases less than 0.5°C at the frequency 1 or 3 MHz. This study shows that ultrasound 
conditions that were used did not promote any dramatic changes in temperature that could 
have been harmful to the cells. 
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igure: A3.1 Standard curve of MTT concentration measured at 570 nm against 3T3 cells 
capsulated in (a): 0.5%, (b): 1% (c): 2% and (d): 5% concentrations alginate disc. 
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A4 Calibration curve of total cell number ( Hoechst assay)  
 
Figure A4.1: Standard curve of fluorescence intensity against 3T3 cells encapsulated in 2% 
concentration alginate disc. 
 
 
Figure A4.2: Standard curve of fluorescence intensity against HDF cells encapsulated in 2% 
concentration alginate disc. 
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Figure A4.3: Standard curve of fluorescence intensity against chondrocytes encapsulated in 
2% concentration alginate disc. 
 
 
 
Appendix 5  Hydroxyproline calibration curve 
 
 
A5 Calibration curve of hydroxyproline content 
 
 
 
F
m
 b a 104 
 
 
igure A5.1: Standard curve for hydroxyproline assay (a): using method A and (b): using 
ethod B 
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A6 Calibration curve for glycosaminoglycan (GaG) content 
 
Figure A6.1: Standard curve of GaG content.   
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